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Investigating the biased processing of emotional faces is essential to our 
understanding of emotional disorders, particularly given the evidence for depression-
related biases in processing positive emotions. The present studies explored emotion 
recognition (ER) in outpatients presenting for assessment and treatment of emotional 
disorders, using an ER task that involved watching 40 computer-morphed faces changing 
from neutral to fully emotional expressions (happy, sad, angry, fearful). In Study 1, 644 
outpatients (57.6% female, M age 31.3, range 18-76) completed the ER task, 
questionnaires, and a clinician-administered, semi-structured diagnostic interview. Study 
2 examined the effect of oxytocin on ER and visual attention in 60 outpatients (61.7% 
female, M age 27.3, range 18-65) using a double-blind, placebo-controlled between-
subjects design. Thirty participants with a current mood disorder and 30 with an anxiety 
disorder (only) received intranasal oxytocin or placebo before completing an ER task 
with eye tracking.  
In Study 1, depression severity was expected to be negatively correlated with ER 
accuracy and intensity. This hypothesis was not supported. Increased age was associated 





primary hypothesis was that oxytocin would improve ER for happy faces in depressed 
participants, based on previous findings that oxytocin enhances ER, and that depression is 
associated with biases in recognizing positive emotions. Diagnostic group (i.e., 
presence/absence of a mood disorder) moderated the effect of oxytocin on ER, but not in 
the expected direction: Oxytocin significantly slowed the speed of ER for all facial 
emotions in participants with anxiety disorders, but did not affect performance in 
participants with mood disorders. The main effect of oxytocin on ER accuracy, speed, 
and fixations in the eye region was not significant. The results were not influenced by age 
or gender. Significant Group x Drug interactions showed that depressed participants who 
received oxytocin made significantly fewer fixations in the eye region of happy and sad 
faces than anxious participants who received oxytocin. Before oxytocin can be used to 
target ER biases, additional research is needed to examine the differential impact of 
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Diminished positive affect and persistent negative affect are core features of 
depression. Cognitive theories of depression have implicated three mechanisms involved 
in the relation between biased cognitive processing and emotion dysregulation that is 
present in mood disorders (Gotlib & Joormann, 2010). These mechanisms are: (1) 
inhibitory processes and deficits in working memory, (2) ruminative responses to 
negative life events and mood states, and (3) the inability to use positive and rewarding 
stimuli to regulate negative mood. The current project investigates the third mechanism 
using oxytocin (OT) and an emotion recognition (ER) task to study the biased recognition 
of positive stimuli (happy faces) in depression and anxiety.  
Emotion Recognition Deficits in Depression and Anxiety 
 Previous research has shown that biased processing of emotional facial expressions 
predicts the course of a depressive episode, recovery from depression, and recurrence of 
depressive episodes (Bouhuys, Geerts, & Gordijn, 1999a, 1999b; Hale, 1998; Persad & 
Polivy, 1993). There have been differences in results across studies for whether 
depression-related biases are based on a general emotion identification deficit (e.g., 
Persad & Polivy, 1993) or a bias in specific emotional expressions (e.g., Gur et al., 1992). 
In a study examining facial ER in children using a forced-choice paradigm, boys at high-
risk for depression based on a family history of depression showed enhanced sensitivity 
in identifying subtle traces of sadness (Lopez-Duran et al., 2013). In another study, 




depression, social anxiety, and healthy controls, and found that compared to controls and 
social anxiety participants, those with depression were less likely to judge subtle happy 
expressions as more intense than neutral expressions (Yoon et al., 2009). This bias for 
happy versus neutral faces was specific to depression, suggesting that those with 
depression are less apt to identify positive affect in subtle facial expressions. A 
depression-specific bias in accurately identifying happy expressions was also shown by 
Joormann and colleagues (2006), who concluded that those with depression required 
significantly greater intensity of a happy facial expression to correctly label the happy 
face than both social anxiety and non-anxious control groups.  
 Social anxiety disorder has also been associated with impairments in facial ER (see 
Staugaard, 2010 for a review). Individuals with social anxiety disorder may be more 
sensitive to detecting threat, and may misinterpret faces as threatening when they do so 
quickly (Heuer et al., 2010). Heuer and colleagues (2010) administered a morphed faces 
task (a task involving watching a series of computer-morphed faces that change slowly 
from a neutral to a fully emotional expression) to socially anxious individuals and non-
anxious controls with time pressure (restricted viewing task, RVT) or with unlimited 
viewing of the faces (free viewing task, FVT). Participants with high levels of social 
anxiety demonstrated a threat bias (disgust interpreted as contempt) in the RVT, 
contrasting with the non-anxious control group’s positive bias (disgust interpreted as 
happy). No group differences were found in the FVT. Other research has examined the 
influence of gender on ER performance in social anxiety disorder. Women with social 




men with social anxiety disorder (Arrais et al., 2009). Men and women did not show 
statistically significant differences in accuracy of judgments or response times. Social 
anxiety disorder has been associated with general, but not specific biases in ER (Button et 
al., 2013). Using a morphed faces task, highly socially anxious participants had a lower 
threshold for identifying emotions, and more frequently classified low intensity emotions 
incorrectly compared to low socially anxious participants. The effects were not emotion-
specific. 
Oxytocin and Emotional Disorders 
OT is a peptide hormone that is synthesized in the paraventricular and supraoptic 
nuclei of the hypothalamus and directly projected into other brain areas, particularly the 
limbic system. Animal studies have established the importance of OT in parturition, milk 
letdown, protective aggression, bonding between mothers and infants and in mating pairs, 
and social behaviors. More recent human studies have confirmed OT’s role as a social 
hormone, involved in forming attachments. In healthy controls, OT has been 
demonstrated to decrease cortisol release and anxiety in response to social stress, reduce 
amygdala activity in response to fearful visual images, increase trust, and increase the 
amount of time spent gazing at the eyes of faces (Cochran et al., 2013).  
 Given that OT directly affects interpersonal and social functioning, use of OT has 
implications for a variety of psychiatric conditions, including autism spectrum disorders, 
schizophrenia spectrum disorders, and mood disorders, all of which show interpersonal 
and social dysfunction as key features (Cochran et al., 2013). Much of the work with OT 




has been conducted on depression and anxiety until recently. In a study where 15 adults 
with autism or Asperger’s disorder were administered OT or placebo, those who received 
OT demonstrated the ability to accurately assign emotional significance to speech 
intonation in a speech comprehension task after a delay, while those who received 
placebo tended to revert to baseline (Hollander et al., 2007). In a more recent case-
controlled study of 17 males with autism spectrum disorder, OT significantly increased 
the accuracy of inferring others’ emotions, suggesting that OT enhances the ability to 
understand others’ social emotions at both the behavioral and neural levels (Aoki et al., 
2014).  
Depression is associated with a range of neurobiological variations including 
hypothalamic-pituitary adrenal (HPA) axis hyperactivity, monoamine, growth factor and 
inflammatory immune functioning (McQuaid et al., 2014). In rats, OT has been shown to 
inhibit stress-indicated activity in the HPA axis through its close association with 
corticotrophic-releasing factor (Rotzinger et al., 2010). OT has been studied for its 
connection to mood and anxiety disorders with conflicting results. The suggestive 
preclinical evidence that OT plays a role in stress response, combined with the 
interrelation of the OT system and mood, suggests that larger clinical studies are needed 
on OT in individuals with mood disorders (Cochran et al., 2013). 
 While research has established that OT improves the encoding and recognition of 
facial expressions in healthy control participants (Fischer-Shofty et al., 2010), less is 
known about whether ER is specifically improved for positive (Di Simplicio et al., 2009; 




blind, placebo-controlled ER and OT study, healthy adults showed decreased reaction 
times to a “reading the mind in the eyes” task (a task in which participants choose a word 
that best describes what a person is feeling/thinking based on a set of eyes) after OT 
administration, and depressed participants had an increased reaction time after OT 
administration (Pincus et al., 2010).  
 In addition to OT and depression studies, researchers have examined the effect of 
OT on social anxiety. A randomized controlled trial of OT as an adjunct to exposure 
therapy for social anxiety disorder demonstrated that participants who received OT 
showed improved positive evaluations of appearance and speech performance in social 
anxiety exposures involving speech tasks. The investigators concluded that following 
exposure therapy, OT improved mental representations of self, and they suggested that 
OT may enhance treatment outcomes for patients with social anxiety disorder (Guastella 
et al., 2009).  
Eye Tracking and Attentional Biases 
A large body of research has provided evidence of the link between emotional 
disorders and attentional biases for emotional stimuli. Eye tracking technology provides a 
direct and continuous measure of overt visual attention, and has been used as an 
important supplement to reaction time measures (i.e., ER scores). In a meta-analytic 
review of eye-tracking and affective disorders, results showed that depressed individuals 
were characterized by reduced orienting to positive stimuli, reduced maintenance of gaze 
on positive stimuli, and increased gaze on dysphoric stimuli (Armstrong & Olatunji, 




region of human faces (Guastella et al., 2008). Enhanced exploration of the eye region of 
the face is likely to improve ER performance because this region conveys the most 
relevant cues for discriminating emotions (e.g., Schyns et al., 2002). In a double-blind, 
placebo-controlled between-subjects design, OT administration had no effect on 
participants’ visual scanning of emotional faces, but it generally enhanced recognition 
performance, as the OT group recognized emotional expressions at lower intensity levels 
(Lischke et al., 2012). These findings indicate that OT-induced improvement of ER is 
independent of modulations in overt visual attention. However, it should be noted that 
this study was conducted with healthy male adults, and the literature has yet to explore 
ER, OT, and eye gaze in men and women with emotional disorders. 
While much of the literature has looked at the eye region as an area of interest in 
emotion recognition, some researchers have defined areas in the lower face (mouth) as 
particularly important in recognizing emotion. Wong et al. (2005) examined patterns of 
visual scanning as predictors of emotion identification in older adults and younger adults. 
Older adults who made more fixations in the top halves of faces were more accurate at 
identifying emotions than those who made more fixations in the lower halves of faces. 
However, for the emotion of disgust in particular, older adult participants were more 
accurate when they fixated on the lower half of the face. In the younger adult group, 
analyses revealed a significant positive correlation between emotion-identification 
accuracy and difference scores computed on the number of fixations made to the top half 
versus bottom halves of faces. A significant correlation pattern was seen for angry, 




patterns for each of the emotional faces when gauging where participants are attending. 
Aims and Hypotheses  
The present studies aimed to (1) examine ER in a sample of outpatients with 
emotional disorders, (2) investigate the effect of intranasal OT on ER performance in 
clinically depressed (DEP) and anxious (ANX) participants, and (3) examine the impact 
of OT on visual attention during an ER task. The study hypotheses were as follows: 
1. Study 1: We predicted that increasing depression severity would be associated 
with slower and less accurate identification of happy faces, and faster 
identification of sad faces. We expected that as participants aged, they would 
become slower in their recognition of negative emotions. This is based on 
evidence reviewed in Chapter 2 (i.e., Isaacowitz et al., 2007). 
2. Study 2: We predicted that there would be differences in the processing of 
emotional faces between DEP and ANX groups. Specifically, the group with a 
clinical depression diagnosis present (DEP) would be slower and less accurate in 
recognizing happy faces compared to the anxiety only group (ANX). We expected 
this because a bias in recognizing happy faces has been shown in depressed 
individuals (e.g., Joormann & Gotlib, 2006; Yoon et al., 2009). We did not expect 
group differences in ER performance for angry, sad, or fearful faces.  
3. Study 2: We predicted that DEP participants who received OT would be better 
able to accurately identify happy faces compared to DEP participants who 
received placebo. OT would not change ER performance for angry, sad, or fearful 




enhance processing of positive versus negative emotional information (Di 
Simplicio et al., 2009). 
4. Study 2: We predicted that there would be group differences in eye gaze fixation 
in emotionally relevant areas of the face (eye region) between participants who 
received OT and those who received placebo. We also explored eye gaze fixation 
patterns between DEP and ANX groups. We did not make a specific prediction 
for which, if any, face types OT would enhance eye gaze fixation.  
5. Study 2: We predicted that here would be a positive association between attention 
to the eye region and ER performance. This was based on the finding that 
attention to the top versus bottom half of faces was associated with better scores 
on an ER task in younger adults (e.g., Wong et al., 2005). 
The present studies add to previous work in two main ways. First, we are not 
aware of any published studies using OT and eye tracking technology to examine ER in a 
diverse anxiety and mood disorder sample. Second, study participants were assessed via a 
semi-structured, clinician-administered diagnostic interview for DSM-5, the Anxiety and 
Related Disorders Interview Schedule for DSM-5 (ADIS-5; Brown & Barlow, 2014), and 
self-report questionnaires allowing for a more comprehensive evaluation of the relations 
among cognitive biases and psychopathology, which can inform classification and 









Participants were recruited from adults seeking services for anxiety and mood-
related concerns at the Center for Anxiety and Related Disorders (CARD). At the initial 
intake (Study 1), participants completed an ADIS-5 interview (described in detail on p. 
11) with a clinical psychologist or advanced doctoral student who had undergone 
extensive training and met strict certification training in ADIS-5 administration. The ER 
task was administered at the initial intake, as part of a series of cognitive processing 
tasks. Once the clinical staffing team at CARD determined a principal anxiety or mood 
disorder diagnosis (diagnostic consensus), study staff contacted interested participants via 
telephone, email, or in person at CARD to confirm eligibility and schedule their Study 2 
appointment. Participants were contacted within one week of diagnostic consensus. All 
participants in Study 1 had a diagnosed emotional disorder (see p. 20 for a breakdown of 
diagnoses). 
Participants completed Study 2 within two weeks of their initial intake. They were 
instructed to abstain from smoking, alcohol, and any nonprescription medication (e.g., 
acetaminophen) for 24 hours, caffeine and exercise for four hours, and food or drinks 
(except water) for two hours preceding the experiment. Adherence to these instructions 
was assessed at the start of the session. Participants were sent an email before the 
experiment to remind them of the date and time of their scheduled appointment and the 




 Eligible participants were men and women  > 18 years of age with a principal 
diagnosis of an anxiety or mood disorder. Exclusionary criteria for both studies were: (1) 
current delusions or hallucinations, (2) current suicidal or homicidal risk meriting 
intervention, (3) two or more hospitalizations in the last 5 years for severe 
psychopathology (psychosis, suicide attempts), (4) not fluent English speakers (those 
unable to complete CARD phone screen and ADIS-5 interview in English). For Study 2, 
additional exclusionary criteria were as follows: (5) pregnancy, (6) a current or past 
autism spectrum disorder diagnosis, (7) regular smokers (smoking > 15 cigarettes/day), 
or consumers of non-prescription or illicit drugs (except for oral contraceptives), (8) 
major sensory impairment and/or visual acuity score (binocular) worse than 20/40, (9) 
those who are currently experiencing a respiratory illness requiring medication (i.e., 
allergy, cold, or flu symptoms), and (10) those who are suffering from a chronic medical 
condition (i.e., heart disease, uncontrolled hypertension, myocardial infarction, cardiac 
arrhythmia, kidney or liver disease, vascular disease, epilepsy, migraine, asthma, 
nephritis, diabetes or another endocrine disease, frequent or unexplained fainting, stroke, 
aneurism or brain hemorrhage, or other neurological illness).  
For Study 2, in the DEP group, clinical diagnoses of major depressive disorder 
(MDD), persistent depressive disorder, other specified depressive disorder, and 
unspecified depressive disorder were accepted (but did not have to be principal). For the 
ANX group, diagnoses of panic, agoraphobia, specific phobia, separation anxiety, social 
anxiety, generalized anxiety, other specified and unspecified anxiety, obsessive-




group could not have a current clinical mood disorder. Participants with two or more 
depressive episodes in the last year who were currently experiencing symptoms that are 
clinically significant but sub-diagnostic threshold (clinical severity rating of 3 out of 8 on 
the ADIS-5 for DEP disorders) were excluded from the ANX group.  
Measures  
 
Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5; Brown & 
Barlow, 2014) 
The ADIS-5 is a semi-structured interview designed to establish a diagnosis of 
DSM-5 anxiety, mood, somatoform, obsessive-compulsive, trauma, and substance use 
disorders, and to screen for other disorders (e.g., psychotic disorders). The ADIS-5 was 
administered by trained Ph.D.-level psychologists and advanced doctoral students in 
clinical psychology who underwent extensive training to meet strict certification criteria 
(see Brown et al., 2001, for details). Reliability testing for ADIS-5 has not yet been 
completed. The ADIS-IV-L, a previous version based on DSM-IV, has been shown to 
have good or excellent diagnostic reliability for most anxiety and mood disorders (κs = 
.67-.86; Brown et al., 2001).  
Beck Depression Inventory-II (BDI; Beck, Steer, & Brown, 1996) 
The BDI-II is a widely used 21-item self-report measure of severity of depressive 
symptoms that are consistent with the diagnostic criteria of major depressive disorders in 
the DSM-5. Total scores range from 0 to 63. The BDI-II has been shown to have strong 
psychometric properties in outpatient samples (Steer, Ball, Ranieri, & Beck, 1997). 




The facial morphing task entails watching “movies” of computer-morphed faces 
that change slowly from a neutral to a fully emotional expression. Stimuli faces were 
taken from Ekman and Friesen’s (1976) Pictures of Facial Affect (see Joormann & 
Gotlib, 2006). After responding to practice trials, participants were shown 40 morphed 
sequences (male and female actor expressing angry, happy, fear, and sad emotion five 
times each) of the faces in random order.  
Using E-Prime software (Study 1) and Matlab software (Study 2), each face was 
presented for 500ms. Study 2 used Matlab instead of EPrime to allow for synchronization 
with eye data collection. The black-and-white face images were approximately 14.5 X 
10.5 cm in size (Study 1) and 12.25 X 9 cm in size (Study 2). Faces were presented in the 
middle of the screen using a black background. Images were presented on a high-
resolution 15” monitor (Study 1) and 18.5” monitor (Study 2).  
Participants were asked to press a keyboard key as soon as they detected an 
identifiable emotional expression. Pressing the key stops the movie and asks participants 
to identify the face as expressing happiness, sadness, fear, or anger. The computer 
records the identification rating and emotional intensity of the face that is displayed at the 
moment of the key press.  
Accuracy scores were based on proportion correct; possible range of scores is 0 to 
1. Intensity scores were based on the intensity of the morphed expression at the time of 
the keyboard press, with possible scores ranging from 0 (neutral) to 100 (fully morphed 
emotion). Higher intensity scores signify that participants required greater emotion to 




Intensity scores were only calculated for trials where participants were accurate. Trials 
where participants pressed the space bar to select face type at 0% intensity (i.e., neutral) 
were not scored as accurate or incorrect, and intensity scores were not calculated. We 
decided to exclude such trials because they almost certainly do not reflect what the test is 
measuring, which is the minimum emotional intensity required to accurately identify an 
emotional face. Additionally, the key press at 0% intensity implies that the participants 
were holding down the space bar when the trial began and never saw the emotional face 
stimulus.  
Design 
For Study 1, participants were individuals who presented for assessment and 
treatment at CARD at Boston University. Participants completed the ER task along with a 
battery of self-report questionnaires and a semi-structured interview as part of their intake 
assessment. For Study 2, approval was obtained from the BU Charles River Campus 
Institutional Review Board (IRB) in Summer 2015. Study 2 was completed in one visit, 
which lasted approximately 90 minutes. Further details of Study 2’s design and 
procedures are described in Chapter 3 (pp. 44-46).  
Data Analysis 
In both studies, SPSS 20.0 and Mplus 7.4 were used to conduct the analyses. In 
Study 1, correlations were conducted to examine the impact of depression severity and 
age on accuracy and intensity of ER performance. 
For Study 2, a sample size of 54 patients provided adequate power (β = .80) to 




analysis of variance (ANOVA). We recruited 30 depressed and 30 anxious participants 
using the eligibility criteria described above. We recruited 6 more participants than 
suggested by the power analysis due to central limits theorem, which indicates that if 
sampling from a normally distributed sample, 30 approximates the population 






Study 1: Emotion Recognition in Outpatients with Anxiety and Mood Disorders 
Introduction 
The ability to accurately identify others’ emotional facial expressions is important 
in social interactions (e.g., Joormann & Gotlib, 2006). Cognitive biases in emotion 
recognition (ER) have been studied across a range of psychiatric conditions including 
depression and anxiety. Individuals with depression have been shown to under-identify 
positive affect in subtle facial expressions (Yoon, Joormann, & Gotlib, 2009). In another 
study, relative to healthy youth, depressed adolescents were more accurate for sad faces 
and less accurate for happy, particularly low-intensity happy faces (Auerbach et al., 
2015). Biases in judging facial expressions may lead to interpersonal problems that 
maintain depression, including perceived lack of reinforcement and decreased experience 
of social support (Gotlib & Hammen, 1992). Changes in ability to recognize emotional 
faces may help in the prediction or monitoring of response to treatment in depression 
(Bourke et al., 2010; Venn et al., 2006). Research exploring the depression-specific ER 
deficits may help improve existing treatments of emotional disorders. 
Facial expressions of emotion represent salient features of the social environment 
(e.g., Ekman & Friesen, 1976; Joormann et al., 2006). Individuals use facial expression to 
interpret others’ interactions, adjust their behaviors, and avoid conflict, and thus, the 
ability to accurately identify and interpret emotional facial expressions is highly 




to result in interpersonal difficulties such as isolation and social rejection (Carton, 
Kessler, & Pape, 1999).  
Early ER research done in inpatient settings reported that depressed patients were 
less accurate in recognition of fearful and angry facial expressions than schizophrenic 
patients and medical patients (Shannon, 1970). Mandal and Bhattacharya’s study 
indicated that depressed patients most correctly recognized sadness and labeled any 
unidentified emotion as sadness (Mandal & Bhattacharya, 1985). In contrast, Ekman and 
colleagues found that depressed patients may be so sad, they perceived others’ sadness as 
happiness (Ekman et al., 1969). 
Although studies have generally found a bias in ER in depression, researchers are 
still examining its specificity, sensitivity, and severity. While some studies have 
demonstrated a distinct impairment in perception of specific emotions and intensities 
(e.g., neutral faces were identified as being sad) (Joormann et al., 2006; Yoon et al., 
2009), other research has shown impairment in the accuracy of facial ER in general 
(Persad & Polivy, 1993). In an early study examining the differences between depressed 
and non-depressed individuals in recognition and response to emotional facial cues, 
Persad and Polivy (1993) compared depressed college students, nondepressed college 
students, depressed psychiatric patients, and nondepressed psychiatric patients on an ER 
task. They found that both depressed groups, relative to the nondepressed college group, 
made more errors in recognition of faces and reported more freezing, tensing, higher fear 
and depressive reactions, a stronger desire to change their reactions, and less comfort 




depressed and nondepressed psychiatric patients. The authors concluded that an 
inappropriate reaction to others’ emotions may maintain or even increase depression 
(Persad & Polivy, 1993). 
There has been a lack of consensus in research studies on the differences between 
depressed, disordered, and control participants on accuracy and intensity of ER. 
Joormann and Gotlib (2006) detailed the inconsistencies in findings, and suggested 
possible reasons including use of artificial social stimuli, and discrepancies in facial 
stimuli. An additional reason for inconsistent findings may be differences in demographic 
characteristics and symptom profiles among samples. It is unclear whether biases in 
identification are specific to depression or whether they characterize other forms of 
psychopathology. Joormann and Gotlib (2006) designed a study to examine accuracy and 
intensities of emotion faces in major depressive disorder (MDD) and social phobia (SOC) 
participants. Comparing groups of healthy controls to patients with MDD and SOC, 
authors found that MDD participants required significantly greater intensity of emotion 
than did the SOC and control participants to correctly identify happy expressions 
(Joormann & Gotlib, 2006). The MDD group, when compared to SOC and control 
groups, required less intensity to identify sad faces. In contrast, SOC participants required 
less intensity to identify angry faces than controls and MDD participants. Yoon et al. 
(2009) expanded this study to explore depression-related biases in processing positive 
affect, again using a sample of MDD, SOC, and control participants. These researchers 
used a forced-choice intensity judgment task rather than the facial morphing task from 




controls and SOC groups, those with MDD were less likely to judge subtle happy 
expressions as more intense than neutral expressions. Additionally, compared with 
control participants, MDD and SOC participants were less likely to judge subtle happy 
expressions as more intense than negative expressions. 
Given the various ways ER has been operationalized across studies, some 
researchers (Joormann et al., 2006; Niedenthal et al., 2002) have suggested using a 
standardized method of defining ER to facilitate comparison of results across research. 
The current study utilizes this standardized method. The ER task used for the current 
study involves computerized faces from The Pictures of Facial Affect Database (Ekman 
& Friesen, 1976) that progress slowly from a neutral expression to one of high intensity. 
Using this task allows for the ability to record the emotional intensity the participant 
requires to make their identification, as well as if they correctly identified the face. This 
process also more closely mimics day-to-day life interactions than emotion identification 
using a single photo, making for a more accurate measurement of the existence of a true 
deficit.  
In addition to depression and anxiety symptoms, another variable that plays a role 
in ER performance is age. A review confirmed that older adults are less accurate in 
recognizing anger, sadness, and to some extent, fear (Isaacowitz et al., 2007). Most 
studies of this nature rely on comparison of a younger cohort to an older cohort, and give 
little information about variation of emotional facial processing across the lifespan. In a 




decline in recognition of sadness and anger starts around 30 years of age (Mill et al., 
2009). 
The primary aim of the present study was to examine ER in a sample of 
outpatients with anxiety and mood disorders. To our knowledge, this the first study to 
explore ER performance in a large, diagnostically diverse sample. Our study is an 
extension of existing research on ER; however, our approach is different because we are 
analyzing depression severity as a dimensional variable rather than using cut scores or the 
presence or absence of an MDD diagnosis to dictate our analyses. This approach takes 
into consideration the heterogeneity of depression symptoms and allows for an 
examination of individual differences in severity above and below the MDD diagnostic 
threshold. Based on prior studies, we predicted that increasing depression severity would 
be associated with slower and less accurate identification of happy faces, and faster 
identification of sad faces. We predicted that age would be associated with slower ER 
performance for negative emotions (anger, sadness, fear). 
Method 
Participants 
Participants were 644 patients who presented for assessment and treatment at the 
Center for Anxiety and Related Disorders (CARD) at Boston University. Patients 
completed the ER task along with a battery of self-report questionnaires and a semi-
structured interview as part of their intake assessment. Women constituted the larger 
portion of the sample (57.6%). The average age was 31.31 (SD = 12.66, range = 18-76). 




7.1%, Other/not reported, .9%, American Indian/Alaskan, .3%, Pacific Islander, .3%). 
The majority of the sample identified as non-Hispanic (91.1%). Diagnoses were 
established using the Anxiety and Related Disorders Interview Schedule for DSM-5 
(ADIS-5; Brown & Barlow, 2014).  
The sample breakdown of principal diagnoses was as follows: coprincipal 
diagnosis (15.2%), panic disorder (3.9%), agoraphobia (2.5%), body dysmorphic disorder 
(0.3%), generalized anxiety disorder (GAD) (20.8%), social phobia (19.9%), specific 
phobia (7.6%), obsessive-compulsive disorder (8.2%), posttraumatic stress disorder 
(2.0%), MDD (4.3%), persistent depressive disorder (PDD) (4.0%), other specified 
anxiety disorder, not resembling GAD (1.1%), other specified anxiety disorder 
resembling GAD (4.3%), other specified depressive disorder (0.8%), personality disorder 
(0.2%), illness anxiety disorder (0.8%), somatic symptom disorder (1.9%), other clinical 
disorder (2.2%). The sample breakdown for MDD and PDD rates (collapsing principal 
and additional diagnoses) was 18.5% and 16.1%, respectively.  
Measures 
Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS-5; Brown & 
Barlow, 2014)  
The ADIS-5 was used to establish diagnoses. See Chapter 1 (p. 11) for a 
description of the ADIS-5. 
Beck Depression Inventory-II (BDI; Beck, Steer, & Brown, 1996) 
For a description of the BDI, see Chapter 1 (p. 11). BDI was rescored (BDI-R) 




BDI includes items that are both specific and nonspecific to the construct of depression. 
Depression-specific items were determined by a factor analysis (see Brown et al., 1998). 
Emotion Recognition Task (“Facial Morphing”)  
See Chapter 1 (pp. 11-13) for a description of the facial morphing task. Outcomes 
analyzed were ER accuracy and intensity scores of happy, sad, angry, and fearful faces. 
Data Analyses 
Correlations were conducted to examine the impact of depression severity and age 
on accuracy and intensity of ER performance. 
Results 
The means and standard deviations of correct identifications (accuracy) and 
intensity of all faces, and happy, angry, sad, and fearful faces are presented in Table 1.1. 
Because ER accuracy and intensity data were non-normal, all analyses were computed in 
Mplus using an estimator robust to non-normality (MLR). In our sample, overall 
accuracy scores ranged from .25 to 1 (M = .88, SD = .11), and overall intensity scores 
ranged from 8.20 to 100 (M = 44.40, SD = 11.12).  
Table 1.1 










Accuracy     .98 (.09)     .92 (.13)     .74 (.19)     .86 (.18) 
Intensity 32.08 (10.31) 48.94 (15.52) 51.03 (15.37) 47.93 (11.73) 





 Correlations were computed to examine the impact of depression severity, based 
on BDI-R scores, on ER. The correlations were not significant, indicating that depression 
severity was not related to ER accuracy or intensity for any face type (range of rs = -.04 
to .02). Additional correlations are presented in Table 1.2. 
Using correlational analyses, we also explored the effect of age on ER. We 
expected that age would be associated with slower and less accurate ER performance. As 
shown in Table 1.2, age was significantly associated with accuracy of ER. As participants 
got older, overall accuracy decreased (r = -.15, p < .001). In examining specific types of 
emotional faces, we found that increased age was associated with decreased accuracy and 
greater intensity required (slower speed in recognition) for sad faces (accuracy: r = -.21, 
p < .001; intensity: r = .13, p < .01) and fearful faces (accuracy: r = -.13, p < .01; 

















































































































































































































































































































































































































































































































































































This study explored the impact of self-reported depression severity and age on ER 
performance. Contrary to hypothesis, depression severity did not play a significant role in 
ER performance. We expected that those with higher depression scores would be slower 
and less accurate at identifying happy faces (i.e., Yoon et al., 2009), and faster at 
identifying sadness (i.e., Auerbach et al., 2015), but did not find a significant effect. 
Age played a significant role in ER accuracy and intensity scores for sad and 
fearful faces, as well as overall accuracy of ER. Increased age was associated with 
significantly slower speed and more inaccuracies in recognizing sad and fearful faces. 
Increased age was also associated with decreased accuracy for all faces. This finding is 
consistent with previous research that has demonstrated an age-related shift in the ability 
to recognize negative emotions (see Isaacowitz et al., 2007 for a review).  
This study builds on existing ER findings through our large and entirely clinical 
sample. Presenting emotions at subtly increasing intensities is more reflective of emotion 
expression in vivo, and therefore allows for a more accurate simulation of the context in 
which individuals need ER skills. This method is more informative and applicable to the 
natural process of facial ER. Conceptualizing depression dimensionally rather than in a 
binary manner (presence or absence of a clinical level of depressive symptoms necessary 
to meet criteria for a disorder), allowed for subclinical symptoms to be included in the 
analysis. Additionally, the dimensional approach allows for exploration of individual 




There are several reasons why our findings may differ from the previous ER 
literature. First and foremost, our sample was diagnostically diverse, with comorbid 
anxiety and mood disorder diagnoses. Other studies that have examined ER and 
depression typically compare a depressed group to a control group (see Joormann & 
Gotlib, 2006; Yoon et al., 2009), and our sample was entirely clinical. Additionally, we 
examined relationships dimensionally within a clinical group. 
Despite the strengths of our study, including the large clinical sample and focus 
on dimensional assessment, it is not without limitations. A lack of consistency in the field 
across ER studies makes results difficult to compare to the previous literature. With prior 
findings ranging from depression improving ER in negative expressions (Joormann & 
Gotlib, 2006), to depression decreasing ER in happy expressions (Gollan et al., 2008; 
Yoon et al., 2009), to depression related ER deficits in identifying neutral expressions 
(Leppänen et al., 2004; Liu et al., 2012), more research is needed. Because the ability to 
quickly and accurately identify a facial expression may be linked to factors such as 
confidence, further studies examining ER performance and response confidence could 
change the way that researchers and professionals interpret social cognition results. For 
example, a recent study by Fieker et al. (2016) examined abnormalities in ER in females 
with MDD compared to healthy female controls, and found that these groups performed 
similarly in ER, with no differences in confidence ratings. However, there was a negative 
correlation between BDI scores and confidence ratings for angry, surprised, sad, and 
neutral expressions, suggesting that more studies investigating depression variables with 




decision-making and enhanced uncertainty may occur, which could be associated with 
social withdrawal and isolation that are common in depression (Fieker et al., 2016). 
Considering that age played a significant role in ER in our study (range of rs  = 
.11 to .21), future research should examine age in more detail, examining factors such as 
memory and other cognitive variables. In a recent study investigating facial recognition 
of happiness among older adults with active and remitted MDD (Shiroma et al., 2016), 
results showed that depressed veterans 55 years and older had a significantly lower 
sensitivity to identify happiness at a moderate intensity of facial stimuli compared to their 
non-depressed counterparts. Additional research should help confirm whether lower 
sensitivity to identify happiness in older adults (and across the lifespan) represents a trait 
marker of depression, and whether it is suitable to intervention.  
Moreover, earlier intervention to target ER biases in children at risk for 
depression and anxiety could potentially lead to reduced rates of psychopathology in 
adulthood. In fact, although it is well established that children of depressed mothers are at 
risk for negative outcomes, a recent study by Tyspes et al. (2016) was the first to examine 
the role of ER biases in children at risk for depression and suicidal ideation. The results 
revealed that children of mothers with MDD were more likely to misclassify angry 
emotions as sad, which predicted the occurrence of suicidal ideation over a 2-year follow-
up, even after accounting for the child’s own diagnoses of MDD during the follow-up. 
These findings highlight ER biases that could be targeted earlier, and suggest that the 
abnormalities in ER are at least partially independent of children’s risk for MDD (Tyspes 




adolescence predict onset of depression at follow-up (Vrijen et al., 2016). This study 
showed that the relative speed of identification of happiness is a better predictor of 
depression during 8 years of follow-up than the identification of the emotion alone. 
Vrijen at al. (2016) suggest that a less active reward system is a possible mechanism 
underlying the predictive role of ER. Additional research is needed to continue to 
examine if ER deficits are a correlate or a predictor of depression severity and/or 






Study 2: A Double-Blind Placebo Controlled Between Subjects Design Examining 
the Effect of Intranasal Oxytocin on Emotion Recognition and Visual Attention 
Introduction 
 In nonhuman mammals, oxytocin (OT) regulates social behavior through 
enhancing social recognition and facilitating reproductive behavior. OT is also well 
known for its role in labor and lactation. In addition to these functions, OT receptors are 
distributed in a variety of brain areas that are associated with parenting, attachment, 
affiliation, social memory, and reactivity to stress (Landgraf & Neumann, 2004). 
Neuropeptides such as OT have been shown to cross the blood-brain barrier when 
administered intranasally in humans, with several studies reporting behavioral effects of 
OT including increasing trust (e.g., Kosfield et al., 2005), promoting interpretation of 
subtle social cues (“mind-reading”) (e.g., Domes et al., 2016), enhancing face memory 
(Guestella et al., 2008; Rimmele et al., 2009) reducing social stress (e.g., Heinrichs et al., 
2003), and enhancing emotion recognition (e.g., Lischke et al., 2012). In a 
comprehensive review of OT and social behavior, Heinrichs and colleagues (2009) 
discuss how OT is released in response to positive social interactions, attenuating 
endocrine responses to stress, and serving as a potential mediator for stress-protective 
effects of social support. 
 Emotion recognition (ER) has been linked to altruistic behaviors (Marsh et al., 
2007), higher relationship quality, and a lower rate of depression (Carton et al., 1999). 




distress, social anxiety, social avoidance, depression, antisocial behaviors, and 
psychopathy (McClure & Nowicki, 2001). Social cognitive deficits such as biases in ER 
predict social function (Shahrestani et al., 2013; Shultz & Dunbar, 2012) and thus the 
enhancement of ER has the potential to improve social functioning in healthy controls 
and across clinical populations.  
A significant limitation of the current research is that much of the work in OT and 
ER has been conducted in healthy control samples with no known deficits in ER. 
Additionally, use of varied methodologies may contribute to inconsistent findings (i.e., 
Guastella & MacLeod, 2012), making results difficult to generalize. While many studies 
report that OT improves the perception of happy faces (Marsh et al., 2010; Schulze et al., 
2011), other studies (Fischer-Shofty et al., 2010) have found a more general effect of OT 
on ER, with OT improving perception of angry, sad, and fearful faces. In a meta-analysis 
examining the effects of intranasal OT on face recognition (Van Ijzendoon & Bakermans-
Kranenburg, 2012), results showed that OT enhances recognition of facial expressions of 
emotions based on a homogeneous set of studies (k = 13, N = 408). The effect of OT on 
ER was significant, but weak (Cohen’s d = 0.02). 
In a more recent meta-analysis of impact of single administration OT on 
recognition of basic emotions in healthy controls, authors collected randomized 
controlled trials of OT compared to placebo (Shahrestani et al., 2013). All studies 
included full-faced photographs presented for at least 300ms, with the ER task involving 
recognizing both positive and negative emotional stimuli. Out of 2,683 studies, seven 




research participants (71 female). The studies used a variety of emotional face stimuli, 
with two studies using The Pictures of Facial Affect Database (Ekman & Friesen, 1976), 
three using images from Karolinski Directed Emotional Faces (Calvo & Lundqvist, 
2009), another using Dynamic Affect Recognition Evaluation from the Cohn-Kanade 
database, and the remaining study using the FACES database, a database of naturalistic 
faces of young, middle-aged, and older men and women (Ebner et al., 2010). Results of 
this meta-analysis showed that OT facilitated ER regardless of facial expression type (g = 
0.291, p < .001, 95% CI: 0.154, 0.429). A moderator analysis showed that OT facilitated 
the recognition of all facial expressions but the effects of happy and fearful faces revealed 
statistically significant results relative to placebo. Additionally, moderator analyses 
showed that OT facilitated the recognition of happy and angry faces under types under 
implicit (< 300 ms) conditions and fear expressions under explicit (> 300 ms) conditions.  
In addition to the limitation of using healthy controls, many OT research studies 
use male-only samples. In a study examining the effects of intranasal OT on emotional 
face processing in women (Domes et al., 2009), the effects OT on brain activity were at 
odds with previously reported effects in men. Specifically, in women who received OT, 
the blood-oxygen-level-dependent signal was enhanced in the left amygdala, the fusiform 
gyrus, and the superior temporal gyrus in response to fearful faces and the inferior frontal 
gyrus in response to happy and angry faces following OT. Males, on the other hand, 
experience an attenuating effect OT on amygdala activity (e.g., Domes et al., 2007). In 




authors concluded that future work should carefully control for anxiolytic and gender 
effects, which may underlie inconsistencies in the existing literature. 
 Interestingly, in addition to being used as an aid in ER, OT is being used as an 
adjunct to exposure therapy for social anxiety disorder. In a randomized, double-blind, 
placebo-controlled trial, Guastella et al. (2009) found that participants who received OT 
before a performance exposure showed improved positive evaluations of appearance and 
speech performance as exposure treatment progressed. While OT improved mental 
representations of self, participants who received OT or placebo reported similar levels of 
symptom severity, dysfunctional cognition, and life-impairment measures following 
treatment (Guastella et al., 2009). 
In more recent years, the impact of OT on depression symptoms has been 
evaluated in empirical research. In a study of the physiological, behavioral, and 
subjective effects of intranasal OT in 18 males with major depression, results showed that 
OT improves social cognition (performance on the reading the mind in the eyes test) 
(MacDonald, MacDonald, Brune et al., 2013). Additionally, the results suggested that OT 
produced an increase in anxiety and a decrease in nonverbal behaviors that cut off social 
contact.  
In another study exploring the effects of OT on automatic and effortful shifting of 
attention to emotional faces, OT was shown to decrease speed in shifting attention to sad 
faces and facilitate disengagement from sad and angry faces in effortful processing 
(Ellenbogen et al., 2012). In automatic processing, depression symptoms moderated the 




attenuated an attentional bias to masked angry faces, suggesting that OT’s influence on 
social behavior may occur by eliciting flexible attentional shifting in early stages of 
information processes (Ellenbogen et al., 2012). An additional study by these authors 
explored the impact on OT on ability to ignore task-irrelevant facial expressions of 
sadness (Ellenbogen et al., 2013). In this randomized placebo-controlled study, 102 
university students between the ages of 18 and 35 completed a negative affective priming 
task with sad, angry, and happy faces. They were instructed to respond to an emotional 
facial expression while ignoring another emotional face, and then the faces were 
switched. Inhibition was operationalized as the difference between responding to a 
previously ignored emotional valence and responding to an emotional valence unrelated 
to the previous one. Results showed no main effect of OT, but the interaction of drug and 
depressive symptoms predicted the inhibition of sad faces. Specifically, participants with 
high depression scores who were given OT had difficulty suppressing the processing of 
sad faces (Ellenbogen et al., 2013). Because OT has been used as an adjunct treatment for 
social anxiety, and depression and social anxiety share features, it is important to 
understand how OT’s cognitive and behavioral effects are moderated by context and 
other factors (Bartz et al., 2011; Ellenbogen et al., 2013). 
Visual Attention  
Additionally, individuals with depression demonstrate attention biases in 
cognitive reaction-time tasks (e.g., Armstrong & Olatunji, 2012). There are distinct 
manifestations of biased attention that have been identified: (1) increased attention to 




attention to positive stimuli (Peckham et al., 2010; Soltani et al., 2015). Some researchers 
have suggested that depression is characterized by elaborative as opposed to automatic 
processing, in direct contrast to anxiety. Teachman and colleagues (2012) proposed that 
attentional biases in depression are conscious and intentional, while anxiety disorder 
attentional biases are unconscious and unintentional. In other words, individuals with 
depression may be no faster than control participants in directing their attention to 
negative stimuli, but once that negative information is captured, they have difficulty 
disengaging their focus (Gotlib & Joormann, 2010).  
 A recent study explored “double attention bias” in 16 patients with major 
depressive disorder (MDD) and 34 never-depressed controls (Duque & Vazquez, 2015). 
The authors found that participants with MDD showed greater total fixation time on sad 
faces compared to controls. They also found a trend in processing positive information, 
with the MDD group spending less total time viewing happy faces than the control group 
(Duque &Vazquez, 2015). 
While the negativity attention bias in unipolar and bipolar depression has been 
well-established, a key question for research is whether those who have recovered from 
depression continue to exhibit attentional biases. Researchers examined this question by 
studying attention to emotional faces in 26 remitted depressed, 16 currently depressed, 
and 33 never depressed individuals (Soltani et al., 2015). Participants viewed sets of faces 
(happy, sad, threatening, neutral) while their eye movements were tracked. Depressed 
and remitted depressed participants attended to sad faces significantly more than never 




attended to happy faces less than controls. Overall, the depressed individuals seem to 
divert their attention away from negative stimuli and towards positive stimuli in a way 
that is likely adaptive, and protective against negative mood states. Trend analyses of 
gaze patterns showed that depressed and remitted depressed individuals did not differ 
from each other in attention to sad faces over time. However, the remitted depressed 
group showed increased gaze towards happy faces over the course of time, similar to 
never depressed controls, although not as sharply (Soltani et al., 2015).  
In a study examining attentional biases towards emotional faces in bipolar 
disorder, participants were separated into groups based on current mood state (euthymic, 
depressed, manic) and viewed four pictures with different emotional valences (happy, 
neutral, sad, and threatening) simultaneously for 20 seconds while their eye movements 
were recorded (Garcia-Blanco et al., 2014). Results showed differential attention for 
happy faces for bipolar patients experiencing depression, suggesting an anhedonic lack of 
sensitivity to positive stimuli. There were no group differences in localization of the first 
fixation on an image, i.e., there were no signs of differential attentional biases in patients 
vs. controls during the earliest states of information processing. Most participants fixated 
first on positive images, which is also typical in healthy individuals (Calvo et al., 2007; 
Garcia-Blanco, 2014). 
Additional research has explored age and gender effects of gaze patterns in 
recognizing emotional faces. Murphy and Isaacowitz (2010) examined older (mean age = 
72.04) and younger adults (mean age = 19.34) using a battery of cognitive, vision, and 




angry, and fearful expressions than younger adults (Murphy & Isaacowitz, 2010). 
Recognition of happy faces was the highest. When younger and older adult gazing scores 
were compared across 24 slides of faces, younger adults gazed more into the eye region 
of faces. Across both groups, accuracy was correlated with more mouth gazing. 
Interestingly, and contrary to the authors’ hypothesis, there was no significant correlation 
between gaze towards the eyes and ER accuracy. 
In a meta-analysis of eye tracking attention in the affective disorders, Armstrong 
and Olatunji (2012) summarized 33 studies using eye-tracking technology to study 
anxiety and depression. Compared to controls, anxious individuals show increased 
vigilance to threat during free viewing and visual search. Anxious participants also 
showed difficulty disengaging from threat during visual search but not during free 
viewing tasks. Depressed individuals, on the other hand, were characterized by reduced 
orienting to positive stimuli, reduced maintenance of gaze on positive stimuli, and 
increased maintenance of gaze on dysphoric stimuli (Armstrong & Olatunji, 2012). These 
authors suggest that the strong anhedonic bias in depression is not unique to depression, 
but also related to low positive affect. Individuals with depression may voluntarily gaze 
less at positive stimuli because they are less sensitive to the pleasantness of it, reducing 
their incentive to maintain gaze.  
OT is known to affect many social and emotional behaviors and enhance 
recognition of emotional faces. Emotional information from faces is thought to be more 
easily detectable after OT administration (e.g., Domes et al., 2007; Marsh et al., 2010; 




attention towards the eye region (e.g., Guastella et al., 2008). Recently, researchers have 
explored the enhanced orienting of attention in response to emotional gaze cues after 
intranasal OT in healthy controls (Tollenaar et al., 2013). In a randomized placebo-
controlled double-blind study, 20 healthy males received OT or placebo and performed a 
gaze cueing task with happy, fearful, and neutral faces. OT significantly increased gaze 
cueing scores for happy and fearful faces relative to placebo. There were no significant 
effects for neutral expressions (Tollenaar et al., 2013). These authors examined the 
moderating effect of trait depression and anxiety, and found no significant results.  
In another study examining the impact of OT on social stress and eye gaze in high 
trait anxious males, Alvares et al. (2012) conducted a randomized double-blind placebo 
controlled trial of 48 participants who self-administered OT and completed an impromptu 
speech task. Eye gaze to a pre-recorded video of an audience was collected, and 
participants completed questionnaires assessing negative cognitive beliefs about 
performance. There was no overall effect of OT on eye gaze or questionnaire measures, 
but the exploratory analyses provide preliminary evidence to suggest that OT can reduce 
negative self-appraisals in men with high trait anxiety (Alvares et al., 2012). Further work 
on gaze in female and clinical samples is needed. 
While a number of previous studies have demonstrated that OT promotes facial 
ER and enhances gaze to eye region, other studies have reported valence-specific effects 
of OT. Domes and colleagues (2013) tested the hypothesis that OT selectively enhances 
eye gaze to positive, approach-related, but not negative, threat-related social cues. In a 




an ER task while eye movement was recorded. The task consisted of 12 video sequences 
with faces that slowly changed from a neutral expression to emotional (happiness or 
anger). Results showed that OT increased eye gaze towards neutral expressions, with 
gaze increasing for happy facial expressions and decreasing for angry expressions 
(Domes et al., 2013). OT did not improve overall ER accuracy or ER for either happiness 
of anger. These findings are in direct opposition to Lischke et al. (2012), who used eye 
tracking to explore visual attention to the eye region on a dynamic facial ER task. 
Lischke and colleagues found that OT had no effect on visual scanning of emotional 
faces, but enhanced ER performance. Participants who received OT recognized emotional 
faces at lower intensity levels than those who received placebo. Participants in both of 
these studies were healthy adult males. 
Further research using eye-tracking technology is warranted to elucidate the role 
of attentional biases in depression, and to determine the impact of intranasal OT on 
attentional biases across mood and anxiety disorders. The current study explored the 
effect of intranasal OT on ER performance in a sample of participants who were 
outpatients at a clinic for mood and anxiety disorders. While the impact of OT has been 
studied in samples of adults with depression and anxiety symptoms, this study is unique 
in that we are using an entirely clinical sample of outpatients with a range of emotional 
disorders to better understand the impact of OT on ER in depression and anxiety. 
Additionally, this study builds on the prior literature through its inclusion of men and 
women. We had four primary hypotheses for this study, and a fifth, exploratory analysis. 




gender, and depression severity on ER and eye fixations. As the majority of OT studies 




The sample consisted of 60 participants who presented for assessment and treatment 
at CARD. Eligible participants were men and women 18 years or older with a principal 
diagnosis of an anxiety or mood disorder. Participants were contacted within one week of 
their initial intake at CARD to complete this study. The average number of days between 
study visits was 11.23 (SD = 2.82, range = 4 to 14). The study was completed in one visit 
of approximately 90 minutes. All participants provided written, informed consent and 
were paid for participation. 
The sample was predominantly female (n = 37; 61.7%), Caucasian (n = 48; 80%; 
Asian = 6.7%; African American = 10%, Other/not reported = 3.3%), and non-Hispanic 
(n = 54; 90%). The average age was 27.33 (SD = 9.94, range = 18 to 65). The majority 
of the sample was right-handed (n = 53, 88.3%) and right-eye dominant (n = 46, 76.7%). 
Most participants (n = 37, 61.7%) used corrective eyewear for the ER task, with 56.7% 
wearing glasses and 5% using contact lenses. Visual acuity was calculated while 
participants used corrective eyewear. The average visual acuity score was above 20/20 
(M = 1.19), and ranged from 0.58 to 1.34 (SD = .17). Based on exclusionary criteria of 




Diagnoses were established using the Anxiety and Related Disorders Interview 
Schedule for DSM-5 (ADIS-5; Brown & Barlow, 2014). When administering the ADIS-
5, interviewers assign each diagnosis a clinical severity rating (CSR) 0-8, representing the 
degree of distress and/or impairment in functioning associated with each diagnosis. 
Diagnoses with a CSR of 4 or higher are considered to be at a clinical level (i.e., at or 
above DSM-5 diagnostic threshold). By design, 50% of the sample (n = 30) met criteria 
for a clinical diagnosis of a mood disorder (DEP), and 50% met criteria for anxiety 
disorders without a mood disorder (ANX). Whereas the ANX group was comprised of 
participants with current anxiety disorders only, the DEP group consisted of participants 
with a current mood disorder in addition to one or more anxiety disorders (although 
participants with a mood disorder without a comorbid anxiety disorder were also 
permitted into the DEP group). Thus, while participants were eligible for the DEP group 
if they had a principal or additional anxiety disorder, individuals in the ANX group could 
not have a diagnosis of MDD or PDD. Additionally, participants with two or more 
depressive episodes in the last year who were currently experiencing just below 
diagnostic threshold (CSR of 3 out of 8) for clinical depression symptoms were excluded 
from the study. The sample breakdown of principal diagnoses was as follows: 
generalized anxiety disorder (23.3%), social phobia (21.7%), coprincipal diagnosis 
(10%), specific phobia (10%), PDD (8.3%), obsessive-compulsive disorder (8.3%), MDD 
(6.7%), body dysmorphic disorder (3.3%), other specified anxiety disorder (3.3%), panic 




specified trauma/stressor-related disorder (1.7%). Of note, 21 of 30 participants (70%) in 
the DEP group had a principal or co-principal anxiety disorder.  
Measures 
As described in Chapter 1 (pp. 11-13) our primary outcome measure for the 
present study was an ER task (facial morphing) completed on a computer. All 
participants had previously completed this task during their initial intake (Study 1). We 
examined ER accuracy and intensity scores for happy, sad, fearful, and angry faces. 
Self-Report 
Beck Depression Inventory-II (BDI; Beck, Steer, & Brown, 1996) 
 See Chapter 1 (p. 11) for a description of the BDI. 
Eye Tracking 
Hardware 
An Applied Science Laboratories Eye-Trac 6 eye-tracking system was used to 
record the position of eye gaze throughout the task. The system has maximum accuracy 
of 0.5 degrees of visual angle, with a resolution of 0.25 degrees. The temporal resolution 
of the camera was set at 120 Hz. A chin rest was used to reduce head movement. After 
adjusting the camera of the eyetracker to be centered on the participant’s dominant eye, 
which was determined using a hole-in-the-card test (see Durand & Gould, 1910), a short 
calibration sequence was administered. The participant looks at 9 points across the 
display monitor, after which the system will be able to accurately and continually 






After the initial 9-point calibration, the accuracy of the system was checked at the 
beginning of each trial for a period of 1500 milliseconds during which the participant 
fixated centrally. An average of the calibration checks across the 40 trials was used to 
refine the original calibration. In each trial, data were analyzed only if valid eye data 
were collected for at least 50% of the trial. If a particular participant lost more than 50% 
of their trials, their data were not analyzed at all. Additionally, if a participant’s data 
showed an overall proportion of less than 50% of fixation data in the face region, the 
participant’s eye data were not analyzed. Of the 60 participants recruited, a total of 13 
were lost due to this system. This system of data reduction eliminates erroneous and/or 
missing data due to various issues with such as calibration, mechanical problems, and 
experimenter error.  
Procedure 
Participants completed a phone screen to determine eligibility. Exclusionary and 
inclusionary criteria are described in Chapter 1 (pp. 9-11). If eligible based on a phone 
screen, a study visit was scheduled within two weeks of intake. Participants were sent an 
email confirming appointment date and time and reminding them of rules for 
participation regarding drug use, caffeine, food, and exercise. Participants were sent an 
email reminder again the day before their scheduled appointment with the same 
information.  
Upon arrival at CARD, participants were consented and randomized to receive 




nurse was not blind to the participant’s assigned drug condition so that she could provide 
the appropriate nasal spray to the participant. The experimenter and participants were 
blind to drug condition. During consent, participants were asked to verify that they had 
not smoked or used drugs or alcohol within the last 24 hours, they had not exercised to 
drank caffeine within the last four hours, and that they had not eaten or drank anything 
with the exception of water within the last two hours. Female participants completed a 
urine pregnancy test facilitated by the study nurse. For female participants over the age of 
menopause (menopause defined as sterilization of not having a menstrual period for the 
last 12 months), pregnancy testing was not performed. Once pregnancy test result was 
interpreted and recorded by study nurse, study nurse assisted in nasal spray 
administration. Female participants’ study visits were approximately 10 minutes longer 
than male’s visit length due to pregnancy testing. For male participants, once consent was 
given, nasal spray was administered. Participants were administered nasal spray OT or 
placebo under the supervision of the study nurse. All participants received a single dose 
of 24 international units (IU) of OT or placebo, intranasally (3 sprays per nostril, 4 IU per 
spray). Administration of 24 IU of OT has been shown to affect behavior in previous 
work (e.g., Bartz et al., 2010; Rilling et al., 2014). Participants did not report any side 
effects of drug administration in the present study. 
After drug administration, participants waited for approximately 40 minutes 
before starting the ER task, as this reflects the standard wait period following intranasal 
OT administration. They were asked to refrain from potentially emotionally stimulating 




They were provided with a standardized selection of magazines to read while in the 
waiting room.  
Approximately 30 minutes into the wait time, participants were moved to the 
testing room. They were administered a brief test of visual acuity. Participants then 
completed practice trials and the ER task. Participants generally began the ER task 
between 40 and 45 minutes following drug administration. The average wait time was 
42.93 minutes (SD = 3.81, range = 40 to 60). The ER task took approximately 20 
minutes.  
Upon completion of the ER task, participants were asked whether they believed 
they received OT or placebo, and they were asked to rate their perceived ability to 
correctly identify the emotions of the different types of faces in a brief 5-item 
questionnaire (i.e., “How accurate were you at identifying happy faces?” 0 = not at all 
accurate, 1 = slightly accurate, 2 = moderately accurate, 3 = very accurate, 4 = extremely 
accurate; see also Appendix A). They were then verbally debriefed about the nature of 
the study, and allowed to ask questions pertaining to their involvement. Participants were 
not informed as to which group they were in. Participants interested in their study 
condition (OT or placebo) gave email contact information to the experimenter to be 
contacted upon breaking the blind. Participants were compensated $40 for their 
participation in this study. The average visit length was 86.60 minutes (SD = 6.99, range 






Data Analyses  
Correlations and regressions were used to test the effect of OT and group status 
on ER performance and visual attention. Additionally, a series of 2 (Drug: OT, Placebo) 
X 4 (Emotional Category: happy, sad, angry, fearful) mixed-model analysis of variances 
(ANOVAs) were conducted to examine the effect of OT on attentional processing of 
emotional faces.  
Eye Fixation Variables 
In addition to dependent variables of ER accuracy and intensity scores, we had 
several dependent variables related to eye fixations. Eye movement parameters reflecting 
the topographical characteristics of scanning behavior were the proportion of fixations on 
previously defined regions of interest of the face: entire face, eye region, and mouth 
region. For the whole trial, we calculated average percent fixation data in the eye region 
relative to data in the face, and mouth region relative to face (see Lischke et al., 2012). 
Fixations were defined as the participant keeping their gaze within a 1 degree area for at 
least 100 milliseconds. Thus, from the reduced eye data, three attentional indices were 
extracted for the present study: (a) proportion of fixation data relative to other data (i.e., 
sum of time length of each fixation during the trial divided by length of the trial) in each 
region of interest (i.e., face, eyes, mouth) for each face type (i.e., happy, sad, angry, 
fearful), (b) number of fixations in each region of interest (i.e., face, eyes, mouth) for 
each face type (i.e., happy, sad, angry, fearful), and (c) time spent fixating (referred to in 
Introduction as fixation duration) in each region of interest (i.e., face, eyes, mouth) for 





ER and Group Status (DEP vs. ANX)  
 ER accuracy and intensity variables for each face type were evaluated for 
normality. Accuracy data were non-normal for each face (all: skew = -1.26 (0.31), 
kurtosis = 2.58 (0.61); happy: skew = -4.24 (0.31), kurtosis = 16.49 (0.61); sad: skew =   
-1.97 (0.31), kurtosis = 3.07 (0.61); angry: skew = -.62 (0.31), kurtosis = -.65 (0.61); fear: 
skew = -1.84 (0.31), kurtosis = 3.76 (0.61)). For intensity data, angry faces were normally 
distributed, skew = .60 (.31), kurtosis = .35 (.61), and Q-Q plots appeared normal. The 
remainder of intensity data for each of the emotional face types was non-normal (all: 
skew = .87 (.31), kurtosis = 1.27 (.61); happy: skew = -.91 (0.31), kurtosis = .89 (0.61); 
sad: skew = .73 (0.31), kurtosis = 1.10 (0.61); fear: skew = .82 (0.31), kurtosis = .98 
(0.61)). To account for non-normal data, all regression analyses were conducted in Mplus 
using an estimator robust to non-normality (MLR).  
The overall accuracy scores (Ms and SDs) for each type of emotional face are 
presented in Table 2.1. In our sample, overall accuracy scores ranged from .65 to 1 (M = 
.92, SD = .07). We predicted that the DEP group would be significantly less accurate than 
the ANX group in identifying happy faces. For happy faces, there was no cell variance in 
accuracy scores because the majority of participants (n = 57) had perfect accuracy scores 
(1). Thus, analyses of this variable were not conducted.  
Mean intensity scores for each type of emotional face are presented by group in 
Table 2.1. Overall intensity scores ranged from 21.03 to 75.53 (M = 40.50, SD = 11.02). 




groups on intensity scores for any face types (p > .05). Descriptive statistics are presented 






















































































































































































































































































































































































































































































ER, Group Status, and Drug Condition 
 
We predicted that relative to depressed participants who received placebo, 
depressed participants who received OT would perform better on recognition of happy 
faces (faster, and more accurate). To test this, we conducted a regression in which ER 
performance (dependent variable) was regressed onto drug condition and group 
(independent variables). The OT group was represented by a dummy code (OT = 1, 
placebo = 0). The regression also examined the interaction between OT and diagnostic 
group (DEP vs. ANX). A positive and significant main effect for OT, meaning that OT 
improves performance relative to placebo for happy faces, would partially support the 
second hypothesis. An interaction term that is positive and significant would support the 
hypothesis that OT improves recognition of happy faces specifically in depression. As 
noted above, we could not examine the outcome variable of accuracy of happy faces due 
to lack of variability. We examined all other ER accuracy and intensity scores. 
Regression results are presented in Table 2.2. Neither main effect for Group, nor 
main effect for Drug were significant predictors of ER. The Group x Drug interaction 
effect was significant and negative for predicting intensity of happy face recognition (B = 
-9.70, p < .05). The strength of the effect was small (f2 = .08). The interaction of intensity 
of happy faces plotted by group and drug status is shown in Figure 2.1. 
Additionally, we examined the main effects and Group x Drug interaction in the 
prediction of other ER outcomes. The significant interaction effects for intensity of all 
faces (B = -15.05, p < .01), happy faces (described above), sad faces (B = -18.02, p < 




while depression status and OT do not independently predict ER performance (the main 
effects were not significant), the interaction of these two conditions significantly 
predicted ER intensity for all of the face types. In predicting ER intensity, the addition of 
the interaction term uniquely accounted for 7% to 14% of the variance. The effect sizes 
of the significant interaction effects were small to medium per Cohen’s (1988) standards 
(f2 range = .08 to .16). 
To further evaluate the interaction of diagnostic group and drug condition on 
performance, we analyzed simple effects. For intensity of happy faces, the omnibus effect 
was 9.70, indicating that the effect of diagnostic group on intensity of happy faces 
differed 9.70 units as a function of the moderator (drug condition). Simple slopes were 
defined as the regression of outcome (intensity of happy faces) on the predictor (Group) 
at a specific value of the moderator (drug condition). Compared to ANX participants, 
DEP participants had significantly higher intensity of happiness scores in the placebo 
condition (simple slope = 6.39, p < .05), but did not significantly differ in the OT 
condition (simple slope = -3.31, p > .05). OT was associated with higher intensity (slower 
speed) than placebo for ANX patients (simple slope = 6.35, p < .05), but this effect was 
not significant in DEP patients where average intensity was 3.35 units lower in OT (p > 
.05). Thus, contrary to expectations, OT significantly slowed performance on happy faces 
for ANX participants, but OT had no significant impact on ER for happy faces in the 
DEP group. 
For intensity of sad faces, the omnibus effect was 18.12, indicating that the effect 




moderator (drug condition). ANX and DEP groups were not significantly different from 
each other in intensity of sad faces scores in placebo (simple slope = 8.76, p  > .05) or OT 
conditions (simple slope = -9.36, p > .05). In ANX participants, OT was associated with 
significantly higher intensity scores than placebo (simple slope = 15.78, p < .001). DEP 
participants who received OT had intensity scores 2.34 units lower (faster) than those 
who received placebo, but the effect as not significant (p > .05). Therefore, OT 
significantly slowed performance on sad faces in ANX participants, but OT had no 
significant impact on the ER performance for sad faces in depression. 
For intensity of angry faces, the omnibus effect was 20.09, indicating that the 
effect of diagnostic group on intensity of angry faces differed 20.09 units as a function of 
the moderator (drug condition). DEP participants were significantly slower than ANX 
participants in the placebo condition (simple slope = 9.77, p < .05) and significantly 
faster than ANX participants in the OT condition (simple slope = -10.32, p < .05). ANX 
participants who received OT had significantly higher intensity scores than ANX 
participants who received placebo (simple slope = 11.19, p < .05). This effect was not 
significant in DEP participants, where average intensity was 8.9 units lower in OT than 
placebo (p > .05). Thus, contrary to expectations, OT significantly slowed performance 
on angry faces in ANX participants, but OT had no significant impact on the ER 
performance for angry faces in DEP participants. 
Finally, for intensity of fearful faces, the omnibus effect was 10.76, indicating that 
the effect of diagnostic group on intensity of fearful faces differed 10.76 units as a 




DEP and ANX participants in placebo (simple slope = 6.43, p > .05) or OT conditions 
(simple slope = -4.30, p > .05). OT was associated with significantly higher intensity than 
placebo for ANX patients (simple slope = 8.51, p < .01). In DEP participants, the average 
intensity was 2.22 units lower in OT than placebo conditions, but the difference was not 
significant (p > .05). Therefore, OT significantly slowed performance on fearful faces in 
ANX participants, but OT had no significant impact on the ER performance for fearful 
faces in depression. 
Taken together, these simple effects tests show that OT had a greater effect on 
slowing ANX participants’ ER performance for all face types than it did on improving 
DEP performance. We expected that OT would make DEP participants faster and more 
accurate in identifying happiness, but this hypothesis was not upheld, as the significant 
Group x Drug interaction effect is not due to OT improving DEP speed, but rather, OT 









Regression Models of Group Status and Drug Condition Predicting Emotion Recognition 
Intensity  
 
Model B  SEB      t p R2 f2 
Intensity of all faces        
1 (Constant) 38.70 2.21 17.48 < .001 .02 .02a 
 
Group .63 2.83 .22    .83   
 
OT 2.93 2.83 1.04    .30   
        
2 (Constant) 34.46 2.02 17.05 < .001 .14 .16a 
 
Group 8.31 3.32 2.50    .01   
 
OT 10.61 3.12 3.40 < .001   
 
Group x OT -15.05 5.27 -2.86 < .001  .14b 
Intensity of happy faces        
1 (Constant) 27.70 1.79 15.44 < .001 .01 .01a 
 
Group 1.45 2.38 .61    .54   
 
OT 1.40 2.38 .59    .56   
 
      
2 (Constant) 24.94 1.64 15.17 < .001 .08 .09a 
 
Group 6.39 2.77 2.31    .02   
 
OT 6.35 2.81 2.26    .02   
 
Group x OT -9.70 4.56 -2.13    .03  .08b 
Intensity of sad faces         
1 (Constant) 41.80 2.98 14.03 < .001 .05 .05a 
 
Group -.48 3.72 -.13    .90   
 
OT 6.54 3.73 1.76    .08   
 
      
2 (Constant) 36.70 2.89 12.71 < .001 .15 .18a 
 
Group 8.76 4.52 1.94    .05   
 
OT 15.78 4.24 3.73    .00   
 
Group x OT -18.11 7.02 -2.58    .01  .12b 
Intensity of angry faces        
1 (Constant) 45.95 3.26 14.12 < .001 .00 .00a 
 
Group -.48 3.58 -.13    .89   
 
OT .94 3.58 .26    .79   
 
      
2 (Constant) 40.29 3.54 11.40 < .001 .14 .16a 
 
Group 9.77 4.47 2.19    .03   
 
OT 11.19 4.57 2.45    .01   
 
Group x OT -20.09 6.64 -3.03 < .001  .16b 
Intensity of fearful faces        
1 (Constant) 41.77 2.07 20.21 < .001 .03 .03a 
 





OT 3.04 2.54 1.20    .23   
 
      
2 (Constant) 38.75 2.11 18.38 < .001 .10 .11a 
 
Group 6.43 3.49 1.84    .07   
 
OT 8.51 3.02 2.82    .01   
 
Group x OT -10.73 4.85 -2.21    .03  .08b 









Intensity of Happy Faces Based on Group and Drug Condition 
 






Eye Fixation Data   
Of our 60 participants recruited, 13 were excluded from eye tracking analyses due 
to erroneous or missing eye data. Of the 47 participants with eye data used in the 
analyses, 22 received OT and 25 received placebo. Of this sample, nine depressed 
participants received OT and 13 anxious participants received OT. Thirteen depressed 
participants received placebo and 12 anxious participants received placebo. See Table 2.3 
for sample characteristics. 
 
Table 2.3 
Differences in Demographic and Clinical Characteristics between Drug Conditions 
 Oxytocin (n = 22) 
M (SD) 
Placebo (n = 25) 
M (SD) 
Age 






       Female 












 A series of 2 (Drug: OT, Placebo) X 4 (Emotion Category: sad, happy, fearful, 
angry) ANOVAs were conducted to explore the relationship between time fixating in the 
face and eye regions and drug status. For the entire face region, analyses showed a non-
significant main effect for Drug, F (1, 45) =  .61, p = .44, a significant main effect for 
Emotion Category, F (3, 135) = 48.51, p < .001, and a non-significant Drug x Emotion 
interaction, F (3, 135) = 2.89, p = .11. Therefore, overall time fixating in the face region 
was not affected by OT administration. 
We expected that OT would enhance gaze to the eye region of emotional faces, 
but this hypothesis was not supported, as the main effect for Drug was not significant (p 
= .85). Analyses showed a non-significant main effect for drug, F (1, 45) = .04, p = .85, a 
significant main effect for Emotion Category, F (3, 135) = 27.54, p = .00, and a non-
significant Drug x Emotion interaction, F (3, 135) = .96, p = .41. Contrary to expectation, 
OT did not significantly increase time fixating in the eye region of faces. Table 2.4 
presents ANOVA results of time fixating in the eye region of each face category by drug 
condition. 
Overall, the significant main effect for Emotion Category in our analyses 
indicates a significant difference in time spent fixating based on the emotion shown. 
Specifically, participants spent the least amount of time fixating on happy faces (M = 
6.09 seconds, SD = 2.99) and the most time fixating on sad (M = 9.32, SD = 4.94) and 
angry (M = 9.38, SD = 4.82) faces regardless of OT administration. Participants spent the 




SD = 2.08) and the most time fixating in the eye region of sad expressions (M = 5.67, SD 
= 3.66) regardless of OT administration. Table 2.5 presents a summary of visual attention 
based on drug status. Table 2.5 and Table 2.7 present proportion of fixation data relative 
to other data in each region of interest (i.e., face, eyes, mouth) for each face type (i.e., 
happy, sad, angry, fearful). For example, “Eye/face” is the proportion of fixation data 
captured in the eye region relative to the proportion of data captured in the face region, 
and “Mouth/face” is the proportion of fixation data captured in the mouth region relative 
to proportion of data captured in the face region (see Lischke et al., 2012). 
Next, we tested the relationship between time fixating in the eye region and 
diagnostic group status. We expected that there would be differences between DEP and 
ANX groups in fixation patterns. Contrary to expectation, ANOVA results showed a non-
significant main effect of Group (p > .05) on time fixating in the eye region of faces. 
Table 2.6 displays ANOVA results based on group status. Table 2.7 presents a summary 









Analysis of Variance of Time Fixations in Eye Region by Drug Status 
 





Time fixating in 
the eye region of 
happy faces 
Between groups 1 .14 .14 .03 .86 
Within groups 45 199.38 4.43  
Total 46 199.52   
Time fixating in 
the eye region of 
sad faces 
Between groups 1 5.85 5.85 .43 .51 
Within groups 45 610.36 13.56  
Total 46 616.21   
Time fixating in 
the eye region of 
angry faces 
Between groups 1 .08 .08 .01 .93 
Within groups 45 538.67 11.97  
Total 46 538.76   
Time fixating in 
the eye region of 
fearful faces 
Between groups 1 .68 .68 .06 .80 
Within groups 45 489.16 10.87  





Summary of Visual Attention by Drug Status 
 Placebo (n = 25) 
 
M                 SD 
Oxytocin (n = 22) 
 
M                  SD 
Sad expressions     
Face/screen .91 .12 .92 .09 
Eye/face .59 .21 .52 .20 
Mouth/face .17 .12 .23 .16 
Happy expressions     
Face/screen .90 .12 .94 .10 
Eye/face .53 .18 .51 .21 
Mouth/face .21 .12 .29 .18 
Fearful expressions     
Face/screen .88 .17 .90 .16 
Eye/face .57 .22 .53 .22 
Mouth/face .16 .14 .23 .16 
Angry expressions     
Face/screen .91 .11 .92 .08 
Eye/face .52 .21 .52 .20 
Mouth/face .18 .15 .26 .15 
Note. Face/Screen = the proportion of fixation data captured in the face region relative to 
data captured outside of the face, on the computer screen. Eye/face = the proportion of 
fixation data captured in the eye region relative to the proportion of data captured in the 
face region. Mouth/face = the proportion of fixation data captured in the mouth region 







Analysis of Variance of Time Fixations in Eye Region by Diagnostic Group (Depression 
versus Anxiety Only) 
 





Time fixating in 
the eye region of 
happy faces 
Between groups 1 4.65 4.65 1.08 .31 
Within groups 45 194.86 4.33  
Total 46 199.52   
Time fixating in 
the eye region of 
sad faces 
Between groups 1 17.60 17.60 1.32 .26 
Within groups 45 589.62 13.30  
Total 46 616.21   
Time fixating in 
the eye region of 
angry faces 
Between groups 1 17.70 17.70 1.53 .22 
Within groups 45 521.06 11.58  
Total 46 538.76   
Time fixating in 
the eye region of 
fearful faces 
Between groups 1 15.87 15.87 1.51 .23 
Within groups 45 473.97 10.53  






Summary of Visual Attention by Diagnostic Group Status 
 Depressed (n = 25) 
 
M                 SD 
Anxious only (n = 22) 
 
M                  SD 
Sad expressions     
Face/screen .91 .12 .92 .09 
Eye/face .59 .21 .52 .20 
Mouth/face .17 .12 .23 .16 
Happy expressions     
Face/screen .90 .12 .94 .10 
Eye/face .53 .18 .51 .21 
Mouth/face .21 .12 .29 .18 
Fearful expressions     
Face/screen .88 .17 .90 .16 
Eye/face .57 .22 .53 .22 
Mouth/face .16 .14 .23 .16 
Angry expressions     
Face/screen .91 .11 .92 .08 
Eye/face .52 .21 .52 .20 
Mouth/face .18 .15 .26 .15 
Note. Face/Screen = the proportion of fixation data captured in the face region relative to 
data captured outside of the face, on the computer screen. Eye/face = the proportion of 
fixation data captured in the eye region relative to the proportion of data captured in the 
face region. Mouth/face = the proportion of fixation data captured in the mouth region 








Table 2.8 provides descriptive information on eye fixation variables by drug and 
group. To test the moderation effect of Group and Drug on eye fixations, we conducted a 
hierarchical regression in which number of fixations in the eye region for each face type 
(dependent variable) was regressed onto drug condition and group (independent 
variables). The OT group was represented by a dummy code (OT = 1, placebo = 0). The 
regression also examined the interaction between diagnostic group and drug condition 
(Group x OT). Regression results are presented in Table 2.9. 
DEP status did not significantly predict number of fixations in the eye region. 
Additionally, OT administration did not predict number of fixations in the eye region. 
The Group x Drug interaction effect significantly predicted number of fixations in the eye 
region for happy faces (B = -8.27, p < .05) and sad faces (B = -15.26, p < .05). Depressed 
participants who received OT made the fewest number of fixations in the eye region 
compared to other groups, and anxious participants who received OT made the most 
fixations in the eye region. Figure 2.2 presents number of fixations in the eye region of 
each face type by drug and group status.  
While we did not make a directional hypothesis about the Group x Drug 
interaction term, it is noteworthy that OT appeared to affect DEP and ANX participants 
in significantly different ways. The size of the interaction effect was small for happy 
faces (f2 = .10) and sad faces (f2 = .10). However, to more closely evaluate the significant 
interaction effects, we conducted tests of simple effects. For happy faces, the omnibus 




the eye region differed 8.28 units as a function of the moderator (drug condition). In the 
placebo condition, there were no significant differences in number of fixations in the eye 
region between DEP and ANX groups (p > .05). DEP participants made significantly 
fewer fixations in the OT condition than ANX participants (simple slope = -6.68, p < 
.05). There were no significant differences between number of fixations in the OT or 
placebo conditions in the ANX group (p > .05) or DEP group (p > .05). Therefore, while 
the mean number of fixations to the eye region of happy faces was significantly higher 
for ANX participants than DEP participants in the OT condition, it did not significantly 
change visual attention for a given diagnostic group in either drug condition. In other 
words, based on these results, we can conclude that OT did not increase attention to the 
eye region of happy faces in DEP or ANX participants. Additionally, when we added 
time as a covariant in the regression analysis, the Group x Drug interaction effect 
remained significant, indicating that the number of fixations in the eye region of happy 
faces was not accounted for by happy face intensity. 
Regarding number of fixations in the eye region of sad faces, the omnibus effect 
was 15.27, indicating that the effect of diagnostic group on number of fixations in the eye 
region differed 15.27 units as a function of the moderator (drug condition). In the placebo 
condition, there were no significant differences in number of fixations between DEP and 
ANX groups. DEP participants made significantly fewer fixations in the OT condition 
than ANX participants who received OT (simple slope = -12.69, p < .05). OT was 
associated with significantly more fixations than placebo for ANX participants (simple 




placebo conditions amongst DEP participants (p > .05). Thus, OT increased number of 
fixations in the eye region in ANX participants, but had no significant effect on visual 
attention in DEP participants for sad faces. Amongst participants who received OT, DEP 
participants fixated significantly less in the eye region than ANX participants in this 
condition. These results indicate a similar pattern as was shown with ER intensity Group 
x Drug interaction effects for sad faces. Because ANX participants who received OT took 
the longest to identify sad faces, we added time as a covariant in our regression analysis 
to make sure that the differences in visual attention were not due to speed alone. When 
time was included in the analysis, the Group x Drug interaction effect was not significant 
(p > .05). Therefore, we can conclude that OT did not manipulate visual attention for 
either ANX or DEP participants. The significant effects for number of fixations in the eye 





Descriptive Statistics for Number of Eye Fixations in the Eye Regions Based on Drug 
Condition and Group Status 
 
























































Regression Models of Group Status and Drug Condition Predicting Number of Fixations 
in the Eye Region of Emotional Faces 
 
Model B  SE B      t p R2 f2 
Number of fixations: Happy faces        
1 (Constant) 14.12 1.71  8.24 <  .001 .03 .03a 
 
Group -2.21 2.00 -1.10     .28   
 
OT -.23 2.00  -.11     .91   
        
2 (Constant) 12.14 1.89 6.43 < .001 .12 .14a 
 
Group 1.60 2.62 .61    .55   
 
OT 3.58 2.26 1.37    .18   
 
Group x OT -8.27 3.86 -2.14    .04  .10b 
Number of fixations: Sad faces        
1 (Constant) 22.13 3.12 7.10 < .001 .05 .05a 
 
Group -4.45 3.64 -1.22    .23   
 
OT 2.67 3.64 .74    .47   
 
      
2 (Constant) 18.48 3.43 5.39 < .001 .14 .16a 
 
Group 2.57 4.76 .54    .59   
 
OT 9.70 4.76 2.04    .05   
 
Group x OT -15.26 7.01 -2.18    .04  .10b 
Number of fixations: Angry faces        
1 (Constant) 22.34 2.89 7.73 < .001 .04 .04a 
 
Group -4.45 3.38 -1.32    .19   
 
OT .00 3.38 .00    .99   
 
      
2 (Constant) 19.47 3.23 6.03 < .001 .11 .12a 
 
Group 1.07 4.48 .24    .81   
 
OT 5.53 4.48 1.24    .22   
 
Group x OT -12.01 6.60 -1.82    .08  .08b 
Number of fixations: Fearful 
faces      
  
1 (Constant) 22.58 2.61 8.65 < .001 .04 .04a 
 
Group -4.18 3.05 -1.37    .18   
 
OT -.53 3.05 -.18    .86   
 
      
2 (Constant) 20.09 2.93 6.87 < .001 .10 .11a 
 
Group .59 4.06 .15    .89   
 
OT 4.24 4.06 1.05    .30   
 
Group x OT -10.38 5.98 -1.73    .09  .07b 


















Association Between Visual Attention and ER Performance  
To determine the association between number of fixations in the eye region of a 
face and accuracy and intensity scores on the ER task, we conducted a series of 
correlation analyses for each emotion category. Correlation results are presented in Table 
2.10. We predicted that enhanced gaze to the eye region of a face would be associated 
with faster and more accurate performance. This hypothesis was not supported. In fact, 
results showed that increased attention (greater number of fixations) to the eye region of 
sad faces was associated with significantly slower responding (i.e., larger intensity 
scores) (r = .35, p < .05). We did not find a significant relationship between accuracy 
scores and attention to eye region for any emotion category (p > .05).  
Next, we investigated the relationship between number of fixations in the mouth 
region and accuracy and intensity scores, and results showed that more fixations in the 
mouth region of sad (r = .31, p < .05), fearful (r = .37, p < .05), and angry (r = .41, p < 
.01) faces were associated with significantly slower responding. Additionally, a greater 
number of fixations in the mouth region of happy faces was associated with significantly 







Correlations between Number of Fixations in Eye and Mouth Regions and Accuracy and 
Intensity Scores 
 
Variable Number of 
fixations in eye 
region of face 
Number of 
fixations in mouth 
region of face 
 
Accuracy of happy faces -.04 -.39** 
Intensity of happy faces  .20  .14 
Accuracy of sad faces  .01 -.03 
Intensity of sad faces  .35*  .31* 
Accuracy of angry faces -.18  .02 
Intensity of angry faces  .16  .41** 
Accuracy of fearful faces  .02  .00 
Intensity of fearful faces -.01  .37* 






Depression Severity, Age, and Gender Predictors 
 
The BDI-II was used to explore the impact of depression symptom severity on ER 
performance. We expected that participants with more severe depression would make 
more errors in recognizing happy faces compared to those with lower depression scores. 
Depression severity did not predict any ER outcomes (p > .05).  
Correlations between age, gender, and depression severity are presented in Table 
2.11 and Table 2.12. We examined the effect of age on ER performance through 
correlational analyses between accuracy and intensity scores and age. Age did not predict 
accuracy of any face type. Intensities of all faces (averaged), angry faces, and fearful 
faces were predicted by age. Older age was a significantly associated with greater 
emotional intensity required to accurately identify all (r = .27, p < .05), angry (r = .29, p 
< .05), and fearful (r = .36, p < .01) faces. Age did not have a significant effect on 
number of fixations in the eye region for any face type (p > .05). 
We examined the effect of gender on ER by regressing accuracy and intensity 
scores onto a dummy code (0 = female, 1 = male). Gender had no effect on accuracy of 
ER. There were significant between-group gender differences for intensity of all faces 
(averaged), happy faces, angry faces, and fearful faces. Interestingly, the only emotional 
face type that gender did not significantly impact was sadness. For all other face 
intensities, females required a significantly lower intensity of the emotional face 
expression to accurately recognize the emotion. A histogram of intensity of happy faces 




Correlations Between Age, Gender, Depression Severity, and Emotion Recognition 
Accuracy (N = 60) 
 
Measure 1 2 3 4 5 6 7 8 
1. Age         
2. Gender .02        
3. BDI-II -.08 -.16       
4. Accuracy 
all faces 
-.03 .09 .11      
5. Accuracy 
happy faces 
.13 .02 -.23 .27*  s     
6. Accuracy 
sad faces 
-.13 .14 .09 .57***     .08    
7. Accuracy 
angry faces  
.03 -.01 .09 .77***     .04     .18          
8. Accuracy 
fearful faces 
-.04 .11 .11 .77*** .31* .39** .28*  






Correlations Between Age, Gender, Depression Severity, and Emotion Recognition 
Intensity (N = 59) 
 
Measure 1 2 3 4 5 6 7 8 
1. Age         
2. Gender  .02        
3. BDI-II -.08 
 
-.16       
4. Intensity 
all faces 
 .27*  .33** .04 
 
     
5. Intensity 
happy faces 
 .17  .44** .03 .89***     
6. Intensity 
sad faces 
 .20  .23 .01 .93*** .76***    
7. Intensity 
angry faces  
 .29*  .29* .07 .90*** .75*** .78***   
8. Intensity 
fearful faces 
 .36**  .27* .02 .93*** .78*** .82*** .81***  






















Relationships Between Eye Gaze and Depression Severity  
 A series of bivariate correlations were conducted to test whether depression 
severity was associated with fixations in various regions of interest. Although we did not 
make specific predictions about this analysis, previous studies have shown a significant 
correlation between fixation time on sad faces and level of depression (e.g., Duque et al., 
2015). Table 2.13 shows the zero-order correlation coefficients. We did not find any 
significant associations between depression severity and eye gaze variables.  
Table 2.13 
Bivariate Correlations Between Time Fixating and Depression Severity 
Proportion of time fixating variable BDI-II 
Sad expression 
     Face 
     Eye 
     Mouth 
 
Happy expression 
     Face 
     Eye 
     Mouth 
 
Fearful expression 
     Face 
     Eye 
     Mouth 
 
Angry expression 
     Face 
     Eye 
























Relationships Between Actual and Perceived Drug Condition and ER Accuracy 
 Participants were asked to rate whether they think they received OT or placebo in 
a debriefing questionnaire following their participation in the study (see Appendix A). 
Participants were generally not accurate in perceiving their drug condition, as only 56.6% 
were correct in their predictions. A 2 x 2 chi-square test was conducted to determine 
actual versus perceived drug condition. The results of this test were not significant, χ2 (1, 
N = 60) = 1.11, p = .29. There was not a statistically significant association between 
actual and perceived drug condition. Additionally, we compared ER accuracy and 
intensity scores between participants who believed they received OT and those who 
believed they received placebo using ANOVA analyses. There were no significant 
differences in ER performance based on whether participants believed they received OT 
compared to placebo. Descriptive statistics are presented in Table 2.14. Table 2.15 




Chi-Square Test and Descriptive Statistics for Actual versus Perceived Drug Condition 
 
 Predicted placebo Predicted oxytocin 
Received placebo 20 (33.3%) 10 (16.7%) 
 









Analysis of Variance of Emotion Recognition Accuracy and Intensity Scores by Perceived 
Drug Condition 
 





Intensity of happy 
faces 
Between groups 1 4.26 4.26 .05 .83 
Within groups 58 5008.01 87.86  
Total 59 5012.27   
Intensity of sad 
faces 
Between groups 1 1.74 1.74 .01 .93 
Within groups 58 12558.93 200.33  
Total 59 12560.67   
Intensity of angry 
faces 
Between groups 1 143.31 143.31 .77 .38 
Within groups 58 10613.12 186.20  
Total 59 10756.44   
Intensity of fearful 
faces 
Between groups 1 1.92 1.92 .02 .89 
Within groups 58 5796.16 101.69  






We also examined the relationship between actual and perceived accuracy for 
each face type. Debriefing questionnaire data were non-normal, and thus, we used the 
Mplus MLR estimator to conduct analyses. We examined the correlations between 
accuracy scores and perceived accuracy and found that for happiness (r = .02) and fear (r 
= .23), there was not a significant association. The relationship between actual accuracy 
scores and perceived accuracy was significant for sad faces (r = .25, p < .05) and angry 
faces (r = .57, p < .001). Taken together, these findings indicate that those who 
performed with high accuracy in recognizing sad and angry faces were more likely to 
perceive that they had done well, whereas actual ER scores for happy and fearful faces 
did not relate to perceived accuracy for these face types. This finding is noteworthy, as 
happy face accuracy scores were the highest of any emotion category, but participants did 
not believe that they had performed as well as they did. 
Next, we created a composite score of the debriefing questionnaire based on 
perceived accuracy for all of the face types (happy, sad, angry, fearful). We regressed the 
composite score (dependent variable) onto group status, drug condition, and Group x 
Drug interaction (independent variables) to evaluate if these variables predicted 
participants’ perceived accuracy. The main effects of Group (B = .69, p = .23) and Drug 
(B = -.69, p = .23) were not significant. Additionally, the Group x Drug interaction effect 
was not significant (B = -.70, p = .54). Therefore, we can conclude that drug condition, 










 The present study used a double-blind, placebo-controlled design to explore the 
impact of OT on visual attention and ER performance. This research was the first of its 
kind, comparing ER performance across genders and diagnostic categories to look at the 
various ways that OT interacts with mood disorder status. While many studies have 
investigated OT’s effects on ER (see Shahrestani et al., 2013, for a meta-analysis) or 
visual attention in affective disorders (see Armstrong & Olatunji, 2012, for a review), this 
study is novel in its exploration of OT and visual attention in a diagnostically diverse 
sample of outpatients with emotional disorders. 
 With regard to ER performance, we expected the DEP group would be slower and 
less accurate in identifying happy faces. This hypothesis was not upheld, as group status 
did not predict accuracy or intensity of ER for happy faces. One potential explanation for 
the nonsignificant main effect of Group on ER is that the clinical severity of mood 
disorders in the DEP group was not high enough to find the conjectured ER deficits. As 
described, ADIS-5 interviewers assigned CSRs for all DSM-5 disorders with noteworthy 
symptoms. In our sample, the severity of mood disorders in the DEP group was relatively 
low (M = 4.8). In fact, 83% of the 30 cases had CSRs no higher than 5 out of 8, which is 
considered in the mild to moderate range of clinical depression. It is possible that the 
level of depression symptoms evident in our sample was not substantial enough to detect 
deficits in ER relative to the ANX group. Future studies should consider recruiting 
participants with an even greater range of clinical mood symptoms, which could aid in 




Our second hypothesis was that DEP participants who received OT would be 
better able to identify happy faces than DEP participants who received placebo. This 
hypothesis was not supported. Based on our significant Group x Drug interaction effects 
for intensity, OT appeared to impact DEP and ANX participants in opposite ways, 
making ANX participants slower and DEP participants faster. With a closer evaluation of 
this interaction effect using simple slopes analysis, the effect of OT on ER performance 
in the DEP participants was not significant. The effect of OT on ER in ANX participants 
was significant, but in an unexpected direction: ANX participants who received OT 
showed significantly higher intensity scores (slower performance) for all face types than 
ANX participants who received placebo. ANX participants in the OT condition 
demonstrated the most impaired (slowest) ER performance for all face types. Perceived 
drug condition had no impact on ER performance. Overall, these findings emphasize the 
importance of considering both contextual and inter-individual factors (see Olff et al., 
2013) to better understand why OT affected DEP and ANX participants differently. 
Perhaps OT increases anxiety in those who already anxious, thus slowing their 
performance. Indeed, our finding that OT slowed ER performance in ANX participants is 
consistent with MacDonald et al. (2013), who suggest that, “...OT has heterogeneous 
subjective effects which may include acute anxiogenesis.” Factors including genetic 
variation, childhood trauma, hormonal status, the salience of the social environment, and 
attachment style may amplify the positive or negative effects of OT for some individuals 




further explored, given our findings that OT had a significant slowing effect for ANX 
participants, but did not impact DEP participants. 
 For visual attention outcomes, we expected there would be group differences in 
eye fixation in emotionally relevant areas (eye region) of the face between OT and 
placebo conditions. Based on prior studies (e.g., Domes et al., 2013; Guastella et al., 
2008), we expected that OT would increase gaze to the eye region of faces. We did not 
find significant main effects for drug status. This inconsistency with the prior literature 
could be due to the fact that much of the eye tracking literature on OT uses healthy male 
participants, or autism spectrum disorder, and we used a clinical sample of men and 
women with mood and anxiety disorders. Additionally, we explored group differences in 
fixation data between DEP and ANX participants. Based on a review of facial emotion 
processing in major depression (Bourke et al., 2010), depression is characterized by 
increased vigilance and selective attention towards sad expressions and away from happy 
expressions. Bourke et al. (2010) indicated several methodological shortcomings in their 
review, including depression heterogeneity, testing paradigms and procedures, and the 
statistical analyses. They recommended that future studies use similar stimuli, citing 
Ekman and Friesen stimuli, to enable data to be compared and pooled. Our study utilized 
these stimuli in an attempt to allow for comparisons with other studies, which was a 
strength of our design; however, we reiterate that the field could benefit from continued 
use of a standardized set of facial stimuli in order to improve generalizability of findings. 




we had anticipated that the DEP group would engage in reduced gaze towards positive 
stimuli (happy faces) compared to the ANX group.  
In our study, the main effects for Group on visual attention were not significant. 
When we examined the Group x Drug interaction effect on visual attention, we found a 
significant effect. Based on this result, it appeared that DEP participants who received 
OT made the fewest number of fixations in the eye region of happy and sad faces 
compared to other groups. Upon further examination, differences in visual attention for 
sad faces were accounted for by time on the task, and because the ANX group in the OT 
condition took the longest, they made the most fixations in the eye region. In the OT 
condition, ANX participants made significantly more fixations than DEP participants in 
the eye region of happy faces. While we expected that OT would increase eye gaze to the 
region of happy faces, OT did not increase attention to the eye region of happy faces in 
DEP or ANX participants. These findings suggest the need for further research to 
examine why OT had a nonsignificant effect in DEP cases in accuracy, speed, and visual 
attention, and a slowing effect on ANX participants. Future investigations should include 
additional variables (i.e., trust, empathy, confidence, time visual stimuli are presented) 
that may account for why the drug manipulation impacted DEP and ANX groups 
differently. 
In a recent double-blind, randomized, controlled study examining the effect of OT 
on attention to angry and happy faces in chronic depression (Domes et al., 2016), 43 
patients received a single dose of OT nasal spray and completed a facial dot probe task. 




eye tracker, reaction times to neutral probes presented at the same location as faces 
depicting happy, angry, or neutral expressions were recorded as a measure of attention. 
OT was shown to reduce allocation of attention towards angry expressions, and sustain 
attention towards happy expressions under conditions of heightened awareness. Based on 
this finding, there was initial evidence for an OT-induced modulation of attention. 
Replication studies are recommended, as well as further evaluation of the usefulness of 
OT in cognitive-behavioral therapy or pharmacotherapy treatment of depression (Domes 
et al., 2016). 
We predicted that increased fixations in the eye region would be associated with 
improved ER performance (cf. Schyns et al., 2002). This hypothesis was not upheld. 
Instead, our results showed a significant negative relationship between number of 
fixations in the eye region of sad faces, and intensity scores (i.e., participants were slower 
if they made more fixations in the eye region). When we further explored patterns of 
fixations, increased fixations in the mouth region was associated with significantly slower 
ER performance in sad, fearful, and angry faces. While previous studies have proposed 
that OT’s enhancement of ER is mediated by increased attention to the eye region, few 
studies have tested the effect of OT on ER through altered eye gaze. In a recent study 
examining the effect of OT on ER and eye gaze used a double-blind, within-subjects 
randomized control experiment of 40 healthy male participants, OT was shown to reduce 
face processing time, while leaving ER accuracy and eye gaze unaffected (Hubble et al., 
2017). This is similar to the previous finding that OT enhanced ER and leaves eye gaze 




current study is that our study used a clinical sample. Another probable reason for 
differences between studies, which was previously mentioned by Lischke et al. (2012) 
and Hubble et al. (2017), is due to the use of dynamic stimuli. Guastella et al. (2008) and 
Andari et al. (2010) suggested that OT was associated with greater dwell-time to the eye 
region, but both studies used static faces. It is also possible that the effects of OT are 
dependent on the ER task requirements, and that tasks where participants are asked to 
make a judgment about a face would bias attention towards the eye region over other 
areas, while OT could have a greater influence on visual attention during a passive 
viewing task where eye-region is less informative or less salient (Hubble et al., 2017). 
We also explored the effect of age, gender, and depression severity on ER and eye 
fixations. Interestingly, self-reported depression severity had no significant impact on ER 
performance or fixations. In our study, gender had a significant effect on ER intensity, 
and women were significantly faster in ER for all face types (averaged). Men and women 
did not differ in accuracy scores. Our findings of gender differences are consistent with 
the literature, which has shown that women are more accurate in recognizing medium 
intensity facial expressions than men (Hoffmann et al., 2010). In another study examining 
the effect of OT on ER in older adults (60 and older) and younger adults (18-30), OT 
improved ER for older males, while no significant effects were shown for older females 
or young adults (Campbell et al., 2014). The authors hypothesized that OT facilitates ER 
by improving neurotransmission for the group with the worst ER (i.e., older males).  
We examined the effect of age on ER performance by correlating accuracy and 




older participants were slower overall, and specifically slower in identifying anger and 
fear, consistent with the previous literature (see Isaacowitz et al., 2007 for a review). 
While the general pattern is one of age-related decline in ER, understanding why older 
and younger adults differ in ER has implications for understanding social interaction, 
communication, and social behaviors across the lifespan (Murphy & Isaacowitz, 2010). A 
recent study on the impact of aging on neural networks involved in gaze and emotion 
processing (Ziaei et al., 2016) used functional magnetic resonance imaging and found 
that younger adults showed neutral sensitivity to eye-gaze direction during angry 
expressions, while older adults showed no effect of eye-gaze direction on neural 
response. Conversely, older adults showed sensitivity to eye-gaze direction during happy 
expressions, while younger adults did not (Ziaei et al., 2016). In the future, age-related 
differences in ER should be studied longitudinally, as this information has the potential to 
be used as biomarkers for early diagnosis of clinical disorders (e.g., autism, 
schizophrenia) where impaired social cognitive abilities are a core feature (Henry et al., 
2016; Ruffman et al., 2008; Ziaei et al., 2016).  
While our diverse clinical sample was a major strength of our research design, 
some limitations should be considered. Due to the lack of research in this area, and the 
failure to standardize ER and eye tracking procedures, the generalizability of findings is 
limited. Additionally, we could not use 13 out of 60 participants’ eye data due to 
mechanical or calibration errors, which limited our sample size by approximately 22%. 




tracking methods or advanced technologies is a recommended direction for future 
research.  
Regarding intranasal dosage and delivery, participants receiving OT self-
administered a nasal spray with the help of a study nurse who primed the nasal spray 
pump (by spraying it) before administration. Thus, while our nasal spray administration 
was standardized as recommended (Guastella et al., 2013), for several reasons, this 
method does not guarantee that each participant received the exact same dosage (see 
Quintana et al., 2016, for a review). First, physical and chemical factors such as stability, 
lipophilicity, and molecular weight can influence intranasal drug delivery. Next, nasal 
cavity physiology can limit the accuracy and consistency of drugs administered nasally. 
Additionally, similar and reliable spray deposition and bioavailability need to be 
achieved. Lastly, the optimal dosage in clinical populations is unknown.  
A final limitation to consider is based on the failure to identify a specific 
mechanism responsible to changes in ER. We attempted to address an underlying 
mechanism for differences in ER performance by examining visual attention, but there 
are other potential mechanisms that may better explain our findings. Future research 
should explore other aspects of depression-related biases in facial processing including 
attentional control and negative interpretation biases. 
Future studies should examine the impact of intranasal OT on depression and 
anxiety symptoms during treatment. McQuaid et al. (2014) discussed using OT as an 
adjunct to antidepressant treatments, or in treating particular aspects of depression. ER 




improvements in ER via OT administration or otherwise would improve the symptoms of 
depression (or anxiety). Treatments that reduce depression may be ineffective in 
preventing their development, and those effective in an intervention capacity may not be 
useful in treatment a preexisting illness (McQuaid et al., 2014). The specific role of OT in 
depression and anxiety treatments requires additional research to clarify the mechanism 
and to better understand its differential impact across disorders. Shahrestani et al. (2013) 
suggest that studies should explore how OT influences holistic vs. featural processing 
(Andari et al., 2010), recognition of emotion expression intensity, or authentic vs. posed 
expressions. An evaluation of ER in the context of traditional neuropsychological 
measures is recommended, as factors such as intelligence, attention, motivation have 
been associated with ER performance (Marsh & Blair, 2008).  
A final point to consider, previously discussed by Hubble et al. (2017), is that 
differences in OT effects across studies may be due to the notion that OT increases the 
salience of social cues and benefits individuals most who are less in tune with social 
information, but does not benefit individuals who are already socially adept. By this 
rationale, perhaps our sample was not low enough in ER at baseline to show 
improvement after OT administration. Indeed, our sample had high ER accuracy scores 
for all faces. Studies that incorporate various additional measures of social cue processing 










 Emotion recognition (ER) deficits in depression have been connected to decreased 
social functioning, conceivably through misidentification or slowed interpretations of 
facial cues. A single dose of intranasal oxytocin (OT) has been shown to improve ER in 
nonclinical samples (see Shahrestani et al., 2013, for a review). While the enhancing 
effects of OT for ER in nonclinical samples have been repeatedly established throughout 
the literature, there was a critical need to determine the facilitative effects of OT on ER in 
emotional disorders, given that ER deficits may be present in this group. This study 
addressed the gap in the literature by examining ER in a clinical sample. Our overall 
objective in these studies was to identify factors (depression severity, depression status, 
age, gender, attention) linked to ER deficits.  
In a recent review of 33 intranasal OT studies (Leppanen et al., 2017), 10 meta-
analyses were conducted to explore the effect of OT on expression of emotion, emotional 
theory of mind, sensitivity to recognize basic emotions, and recognition of basic 
emotions. Based on this, OT did not significantly influence expression or interpretation of 
basic emotions among clinical samples. OT showed significantly improved ER in 
nonclinical samples, with a specific improvement in recognition of fear. Leppanen and 
colleagues (2017) discuss how OT may be of evolutionary significance in nonclinical 
samples, increasing approach and attention towards safe stimuli, and increasing 
defensiveness towards unsafe stimuli (e.g., Olff et al., 2013). However, these effects are 




DEP or ANX participants, who may have a preexisting bias in interpretation of social 
interactions as “unsafe.”  
Previous studies have suggested that perception and recognition of emotions is 
altered in personality disorders (Domes et al., 2009). The present studies utilized a well-
established, thorough, semi-structured clinical interview of anxiety and related disorders 
(ADIS-5), but did not systematically screen for personality disorders, which could have 
played a role in our findings. Additional factors that our study did not control for, 
including early parental care and attachment style (Olff et al., 2013, Fang et al., 2014) 
have been shown to moderate the effects of OT. Di Simplico and Harmer (2016) 
suggested that future research should examine whether variability in early life 
experiences and individual traits corresponds to endogenous OT levels. Moreover, 
differences in the impact of OT in clinical and nonclinical samples may be due to 
differences the brain system, gene patterns, and OT release, determined by genetic and 
epigenetic factors (Neumann & Slattery, 2016). High central OT availability has been 
linked to an anxiolytic, prosocial, and socially competent phenotype, whereas diminished 
OT and receptor interactions have been associated with elevated nonsocial anxiety, fear 
in social settings, and a lack of social preference (Neumann & Slattery, 2016). In sum, 
substantial heterogeneity, comorbidity, and individual differences within diagnostic 
groups provide potential explanations of nonsignificant effects of OT on ER in clinical 
samples (Leppanen et al., 2017).  
More research is needed to clarify baseline ER differences across clinical 




and speed are linked to reduction in depressions symptoms across treatment, and whether 
ER performance is malleable in a clinical sample without antidepressant drugs such as 
selective serotonin reuptake inhibitors (SSRIs) and neuropeptides such as OT. In a study 
of the effects of short-term SSRI administration on ocular face exploration, SSRIs were 
shown to modulate attention biases by increasing gaze maintenance over the internal 
features of faces in a sample of 50 participants from the general population (Di Simplicio 
et al., 2014). Future ER research should control for medication effects in clinical samples. 
Limitations 
 Limitations of our studies are discussed specifically in prior chapters (pp. 25, 82-
83). More generally, there are additional limiting factors that we recommend future 
researchers take into account. First, because happiness is one of the most easily 
recognized emotional expressions universally (Ekman et al., 1987), there are often ceiling 
effects (Isaacowitz et al., 2007; Murphy & Isaacowitz, 2010). In Study 2, 95% of the 
sample (n = 57) had perfect accuracy scores (1.0) for happiness, and the other 5% (n = 3) 
had scores of .90. Overall accuracy for our sample in Study 1 was 88%, and for Study 2, 
it was 92%. In our studies, happiness was the only positive expression among four 
expressions; thus, likely easiest to recognize by this design artifact alone. Future studies 
should present more than one positive expression (i.e., surprise, pride) in order to clarify 
the effect of OT on ER for a range of expressions. Additionally, future studies should 
establish guidelines for reducing ceiling effects of happiness ER, as such effects make if 
difficult to find the true impact of OT since performance is already at a peak (see 




Another limitation to consider is the ecological validity of ER testing on a 
computerized task. Though they are widely used, the Ekman and Friesen (1976) stimuli 
have been criticized regarding generalizability, and whether they are indicative of 
universal ER (Murphy & Isaacowitz, 2010; Russell, 1994). Future work should 
incorporate more real-world processing through video, virtual reality, or exposure with 
people (Raes et al., 2006). 
Finally, there are still uncertainties about the mechanism of action in intranasal 
OT. Questions have been raised regarding if and how intranasal OT accesses the brain 
(Leng & Ludwig, 2016). It is also still unknown if aging is accompanied by and increase 
or decrease in central and peripheral release of OT, and if age-related differences in OT 
system dynamic underlie differences in social-emotional functioning (Ebner et al., 2013). 
Answering these questions to provide a complete picture of how and why OT impacts 
individuals in very different ways is an essential step before OT it can be used in clinical 
samples.  
Overall Conclusions and Future Directions 
 Despite the growing body of literature on the effects of OT on emotion 
processing, it is unclear whether the facilitative effect precedes, is independent of or even 
secondary to OT promoting a greater salience of social stimuli (Di Simplicio & Harmer, 
2016). OT produces neurofunctional and behavioral outcomes that seem to be completely 
dependent on the experimental context and on individual differences including gender, 
personality, and life experiences. Di Simplico and Harmer (2016) suggest that “while the 




positive emotion bias – in particular in facial expression processing – appears simplistic, 
the association and hierarchy of oxytocin effects on emotional and social stimuli remains 
to be fully understood” (p. 1157). 
The difficulty disentangling mechanisms involved in OT’s role in human behavior 
may be due to the idea that most emotional cues used in experimental designs are of a 
social nature, and most paradigms used include both positive and negative social stimuli. 
The results of previous OT studies are complex and often contradictory, and future 
research should continue to investigate interactions between individual and contextual 
characteristics to determine when and for whom OT promotes social behaviors. Factors 
including early life stress experiences and motivational processes (see Feeser et al., 
2014), as well as placebo effects, should also be taken into account. 
 Because considering the context and individual factors is key in clarifying the 
clinical applications of OT, one specific population that OT should be further 
investigated is women with postpartum depression. Depressed mothers are less likely to 
accurately identify infants’ happy facial expressions than non-depressed controls 
(Arteche et al., 2011). In a recent study examining the effects of intranasal OT on 
sensitive caregiving in mothers with postnatal depression, mothers who received OT were 
more likely to rate an infant cry as more urgent, and they were more likely to choose a 
harsh caregiving response (Mah et al., 2017). Depressed mothers also have a decreased 
neural response to positive infant signals, including smiling (Wonch et al., 2012). Mah 
and colleagues (2017) expected that OT would enhance a depressed mother’s ability to 




finding that OT increased harsh caregiving should be further explored, as OT may induce 
an iatrogenic effect. Given the potential of iatrogenic effects, further research is needed to 
consider use of OT administration on depressed mothers of infants. Additionally, as 
recommended originally by Van Ijzendoorn and Bakermans-Kranenburg (2012), an 
exciting area for future OT is the in cognitive-behavioral interventions for marital 
problems, and interaction-focused parent training, where perceptions of emotions in a 
partner or child could be facilitated by OT as an additive component of treatment. 
In conclusion, these studies examined ER in emotional disorders using a dynamic 
facial morphing task. Our findings indicate the need for future OT studies in clinical 
samples, with additional variables (including personality factors and context) that can 
explore mechanisms for differences in ER abilities and performance. Additionally, based 
on our results, the role of depression on ER is unclear. Ultimately, future studies aimed at 
correcting ER biases could be developed as an adjunct treatment for emotional disorders, 
but it is not yet determined what, if any, role of OT would play in this intervention. More 
research and replication is needed to draw conclusive and consistent evidence about the 












1. Do you think that you received (circle one): 
 
Oxytocin    Placebo 
 
 
The following questions are rated on a 0-4 scale (0 = not at all accurate, 4 = extremely 
accurate). For each item, please circle one number. 
 










2. How accurate 
were you at 
identifying 
happy faces? 
0 1 2 3 4 
3. How accurate 
were you at 
identifying sad 
faces? 
0 1 2 3 4 
4. How accurate 
were you at 
identifying 
angry faces? 
0 1 2 3 4 
5. How accurate 
were you at 
identifying 
fearful faces? 
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